Your SlideShare is downloading. ×

Uk norway ib directory

2,365

Published on

Published in: Technology, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
2,365
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
69
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Contents Welcome 5 About the UK-Norway agreement 7 Technology Strategy Board 8 Biosciences Knowledge Transfer Network 10 Innovation Norway – connecting, informing and funding 12 Norwegian Industrial Biotechnology Network 14 Useful Contacts 16 A-Z Listings 22 Directory designed & produced by Benham Publishing Limited 4th Floor, Orleans House, Edmund Street, Liverpool L3 9NG Tel: 0151 236 4141 Fax: 0151 236 0440 Media No: 1335 MEMORANDUM OF UNDERSTANDING between Appendix 1 – Proposed Activities 48 Index of Advertisers 49 Disclaimer Benham Publishing Limited cannot be held responsible for any inaccuracies that may occur, individual products or services advertised or late entries. No part of this publication may be reproduced or scanned without prior written permission of the publishers. Check your details! 50 ©Copyright Benham Publishing Limited 2013 INNOVATION NORWAY and the TECHNOLOGY STRATEGY BOARD 46 3
  • 2. Welcome This directory is designed to foster business driven R&D partnerships within industrial biotechology. It has been inspired by the "Memorandum of Understanding", signed by the UK and Norwegian innovation agencies in 2011, outlining a series of activities to be undertaken on industrial biotechnology and biorefining. Industrial biotechnology is the use of biologically-based technologies, such as fermentation or biocatalysis, to develop new and more efficient and sustainable methods of producing energy, chemicals and materials. Biorefining is the identification, extraction and modification of valuable components from a biobased feedstock to support the biotechnology process. The UK-Norway partnership has so far led to eight co-funded projects and a variety of other shared activities. With the formation of the Norwegian Partners in innovation Industrial Biotechnology Network, identification of new innovation projects The Technology Strategy Board and Both organisations value the use of will continue with greater impetus. Innovation Norway promote innovation knowledge exchange to inform and in a number of ways - the main route is generate new partnerships. The UK’s The directory lists over 250 through grant-funding innovative KTNs, in particular Biosciences and organisations and provides an excellent projects. Companies are co-funded to Chemistry Innovation, and the resource to identify future partners. undertake additional, higher risk Norwegian Industrial Biotechnology Industrial biotechnology and biorefining projects than they can finance solely at Network will continue to organise joint can provide both a valuable and their own cost. A summary of the joint, knowledge exchange activities, such as sustainable route to the production of collaborative projects funded so far is workshops, to inform and provide chemicals, materials and energy. included. networking opportunities. 5
  • 3. About the UK-Norway agreement On the 23rd February 2011, Innovation Norway and the Technology Strategy Board signed a memorandum of understanding to collaborate on a number of activities focusing on industrial biotechnology and biorefining. These technologies underpin the bioeconomy, which in Europe has a market size of €2 trillion and employs 21.5 million people. Investment in these technologies could help to meet the increasing demand for a sustainable supply of food, industrial products and fuels. Both organisations believe that through joint activities, such as knowledge exchange and innovation projects, they will generate future economic growth. During the last two years, the partnership has: • commissioned research to map UK-Norway opportunities • contributed or commissioned five technical reports • committed investment of over €2m into eight joint projects. The project participants include seven UK companies, eight Norwegian companies and one UK university. Two projects will be launching products this year. In addition, the partnership: has • contributed content to over 20 events • 100 individuals and organisations registered in online networks • encouraged closer co-operation between its countries’ research and technology organisations. Projects funded: Norwegian Project Size (€k) Pilot-scale production of a biologically active GlycoMar polysaccharide from a marine microalga using photobioreactor technology MicroA 190 AMarineIB - Bioprocessing of sustainable marine resources for the production of highvalue chemicals Centre for Process Innovation Marine BioProducts 235 Production of natural marine functional ingredients for skin care Aquapharm Aqua Bio Biodiscovery Technology 230 Engineering cellulose using biotechnology Unilever, Croda Borregaard 1,040 Centre for Process Innovation AlgiPharma 350 Development of a scaleable, sustainable Biocatalysts manufacturing process for a novel, high-value polypeptide Seagarden 195 Development of a in vitro living skin equivalent Epistem for testing anti-inflammatory substances ScandiDerma 450 2011 UK 2012 ALGIFERM - Alginate oligomers by fermentation High-value chemicals by biotechnological modifications of polysaccharide from waste Unilever, Seagarden Glyndwr University, Croda, Almac 1,435 Further funding will be available in 2013 for UK-Norway projects. 7
  • 4. Technology Strategy Board The Technology Strategy Board is the UK’s innovation agency. Our goal is to help accelerate economic growth by stimulating and supporting business-led innovation. Our programme and support for business innovation are a key part of the Government’s industrial strategy. Our work in priority areas and our support for business innovation are key parts of our strategy. We helped to identify the ‘eight great technologies’ at the heart of the UK’s push for growth. We are setting up seven new Catapult technology and innovation centres, and all will be operational this year. They will provide a powerful new force for innovation in the UK. The High Value Manufacturing Catapult hosts the National Industrial Biotechnology Facility. Our view extends far beyond the UK to European and global opportunities which includes launching joint programmes with the key emerging economies of India and China. Everything we do is driven by the desire to help UK business bring new ideas and technologies to market. The Technology Strategy Board builds strategic partnerships with key organisations. It connects and creates engagement between people and organisations, which might not normally work together, and acts as a catalyst to enable developments that otherwise would not take place. The agreement with Innovation Norway is the first bilateral with another innovation agency but follows other UK-based partnerships. In 2013, it announced its partnership with BBSRC on an Industrial Biotechnology Catalyst. Our strategy for business innovation Concept to Commercialisation has five key aims: • Accelerating the journey between concept and commercialisation • Connecting the innovation-support landscape • Turning government action into business opportunity • Investing in priority theme areas based on potential • Continuously improving our capability. Our 2012 ‘Biosciences’ strategy focused on the following priority areas: genomics, industrial biotechnology, agriculture and food. Industrial biotechnology, encompassing biorefining, offers the opportunity for more efficient chemical processes and the generation of sustainable energy and materials. Over 55 industrial-biotechnology using projects have been funded through a series of ‘high-value chemicals’ competitions, which were initiated in 2009. These projects are in addition to others funded through some of our other programmes such as Smart, Knowledge Transfer Partnerships and ERANETs. Our ‘Enabling Technologies’ strategy will focus biosciences investment in three areas: characterisation and discovery tools, production and processing and bioinformatics. Our current ‘High Value Manufacturing’ strategy identifies 22 national competencies for investment including biotech, biological and synthetic biology. Through implementation of these strategies, the Technology Strategy Board hopes to generate wealth-creating, innovative projects in the future. 8
  • 5. Photo supplied by Rothamsted Research
  • 6. Biosciences Knowledge Transfer Network Knowledge sharing and open innovation help companies engage with the ideas and opportunities around them. This is the purpose of the 15 businessled KTNs, which have more than 30,000 individual members. In 2010, the Technology Strategy Board created an online collaboration and social networking tool, _connect, which hosts the KTNs together with many other groups. 10 KTNs are a dynamic resource for individuals to enable business innovation by sharing knowledge, ideas and opportunities within and between specific sectors. One of these is the Biosciences Knowledge Transfer Network which drives the conversion of the United Kingdom’s bioscience knowledge into innovative agricultural, food and industrial bioscience products and processes for the benefit of business, the economy, the environment and society. The KTN serves four identified market sectors: • Industrial bioscience • Animal breeding and animal health • Plant breeding and crop protection • Food technology and manufacture Biosciences KTN puts companies and innovators in contact with the funding and knowledge that they need to bring new products and processes to market. Our aim is to connect and catalyse by: • Driving knowledge transfer between the science base and industry • Creating networking opportunities and stimulating innovation key to our industry sectors • Providing a coherent voice for industry to inform government policy. The Biosciences KTN can help innovation by integrating academic, industrial and business communities within and across sectors that may not have previously interacted closely. We combine the knowledge and expertise of all stakeholders, offering new opportunities for business or research enhancement. Biosciences KTN can: • Provide access to and advice on funding and collaboration opportunities • Mentor funding applications • Help build partnerships and identify new business opportunities • Provide free access on latest developments, events and funding opportunities through our online _connect website (www.innovate.org/biosciencesktn) Hosted by the KTNs, there are also Special Interest Groups (SIGs) created to work across KTNs on specific tasks. One of these is the Industrial Biotechnology SIG (IB-SIG). Set-up 3 years ago, its purpose is to encourage UK industry to utilise industrial biotechnology to create chemicals more efficiently and sustainably. This has been achieved under strategic direction from the Industrial Biotechnology Leadership Forum and on-the-ground has visited over 100 companies across the country. Several of these have proceeded to test the feasibility of using industrial biotechnology in their current work.
  • 7. Innovation Norway – connecting, informing and funding Innovation Norway connects people, businesses and communities across borders. Our key objectives are to nurture business innovation and entrepreneurship, foster regional development, international cooperation and market access. We build local business networks in key markets through our more than thirty offices around the globe. 12 Innovation Norway is the main government agency for industry development, with close to 800 employees and about €800 million in grants and loans under management. In addition to its international offices, the organisation has business units in all Norwegian counties, which provides a unique knowledge of Norwegian companies in all sectors. Innovation Norway acts as an advisor to the Government on industry policy in close co-operation with the Norwegian Research Council. For instance, both organisations were strongly involved in preparation of the Government’s white paper on biotechnology, which was published in December 2011. Based on the recommendations drawn up in the national biotech strategy, Innovation Norway has recently launched a new program to support the emerging bioeconomy. This initiative has several measures, with the key objective to stimulate innovation and investments into sustainable production of high value products. We support projects along the whole value chain from market investigations, technical feasibility and scaling up of novel processes. In 2013 we aim to invest about €8,5 million in industrial biotechnology and biorefining, a figure we hope to gradually increase in future years. It is our ambition to help Norwegian companies become leaders in the use of renewable resources, e.g. efficient value creation from wood or marine derived biomass, areas where Norway by tradition is strong. We firmly believe, however, that cooperation is crucial, particularly with respect to progressing the bioeconomy. Establishing the Norwegian Industrial Biotech Network and seeking a partnership with the UK, illustrate our emphasis on connecting people. It is people who run businesses. We hope that this directory will foster new business collaborations across the North Sea.
  • 8. Norwegian Industrial Biotechnology Network Growth of the bioeconomy depends on the interplay between renewable feedstock, new technology and emerging markets. The Norwegian Network for Industrial Biotechology connects business and knowledge across sectors and geography. The network’s focus is on biotechnology in conversion, valorization and manufacturing processes based on raw materials from agriculture, forestry and the marine sector. The overarching mission is to create value for society through economic growth, as well as a more sustainable industry. 14 The activities reflect four strategic objectives: • Facilitate cross-sectorial and multidisciplinary networking • Identify and communicate market opportunities • Promote investments by competent capital • Increase awareness of industrial biotechnology in society We organise seminars, workshops and study tours in order to disseminate knowledge, alone or in cooperation with partner organisations or Government agencies. We communicate business news, market information, new grant programs and help the grant providing agencies identifying new projects. Norwegian Industrial Biotechnology Network was established in 2011 and has currently over 50 institutional members. These members include companies from all relevant sectors, as well as the most prominent research organisations in Norway. Our website offers a gateway to the Norwegian biotech industry, providing a comprehensive list of relevant companies, members as well as nonmembers. www.indbiotech.no We respond to international enquiries and help companies in their search for business partners. We also make connections to academic centres of excellence and Government support agencies, such as Innovation Norway, The Norwegian Research Council or Invest in Norway. Our office address is in the city of Trondheim, centrally located in Norway and home to the Norwegian University of Science and Technology, as well as several large RTOs.
  • 9. Useful Contacts Cristian Strømmen UKTI Director - Oslo UK Trade & Investment, British Embassy Oslo cristian.strommen@fco.gov.uk +47 23 13 27 64 Ernst Kloosterman Managing Director Norwegian Industrial Biotechnology Network ernst@indbiotech.no + 47 957 43 945 www.indbiotech.no Ewa Bloch National Contact Point – Industrial Biotechnology Technology Strategy Board ewa.bloch@tsb.gov.uk www.innovateuk.org Marit Valseth Coordinator Bioeconomy Innovation Norway marit.valseth@innovationnorway.no +47 909 66 998 www.innovationnorway.no Merlin Goldman Lead Technologist – High Value Manufacturing Technology Strategy Board merlin.goldman@tsb.gov.uk +44 (0)7824 600053 www.innovateuk.org Michelle Carter Knowledge Transfer Manager Biosciences KTN michelle.carter@biosciencektn.com +44 (0) 131 6517332 www.innovate.org/biosciencesktn Ole Jørgen Marvik Sector Head, Health and Life Sciences Innovation Norway ole.jorgen.marvik@innovationnorway.no +47 911 95 876 www.innovationnorway.no 16
  • 10. A-Z LISTINGS Aber Instruments Contact: John Carvell, Sales and Marketing Director Science Park, Aberystwyth, SY23 3AH T: +44 1970 636303 E: johnc@aberinstruments.com W: www.aber-instruments.co.uk Advanced Extraction Technology Ltd Contact: Gary Wheatley, Scientific Director Old School House, 47 Rowley Road, Little Weighton, North Humberside HU20 3XJ T: +44 1482 842570 E: info@advancedextractiontechnology.co.uk W: www.advancedextractiontechnology.co.uk Based on research activities at the University of Abersytwyth and the centre for Alternative Technology (Machynlleth, UK) Aber Instruments was founded in 1988. The company invented and patented a unique method for measuring live biomass based on Radio-Frequency Impedance. Advanced Extraction Technology has concentrated on exploiting the emerging green technology of Sub-critical Water Extraction (SWE) which can replace harmful organic solvents in the production of pharmacologically active extracts from plant based raw material. Advanced Pest Solutions Ltd Aesica Pharmaceuticals Contact: Alison Blackwell, Director Prospect Business Centre, Gemini Crescent, Dundee Technology Park, Dundee DD2 1TY T: +44 1382 561696 E: ablackwell@advancedpestsolutions.co.uk W: www.advancedpestsolutions.co.uk Contact: Steve Barker, Site Director Windmill Industrial Estate, Shotton Lane, Cramlington, Northumberland NE23 3JL T: +44 1670 590595 E: steve.barker@aesica-pharma.com W: www.aesica-pharma.co.uk Advanced Pest Solutions Limited (APS) is an innovative biocontrol company, developing technologies which address an increasing need for effective and environmentally-sustainable replacements for synthetic chemicals. Our state-of-the-art facilities enable delivery of a full API development and manufacturing, formulation development and formulated products manufacturing services in a growing number of markets. Agroplas AS Akcros Chemicals Ltd Contact: Bjørn Utgård, CEO Parkveien 57, 121, OSLO, Norway M: +47 920 88 057 E: bjorn@agroplas.no W: www.agroplas.no Contact: Paul Fyfe, Plant Scientist Lankro Way, Eccles, Manchester M30 0LX T: +44 161 785 1163 E: paul.fyfe@akcros.com W: www.akcros.com Novel technology for drying, grinding and processing biomaterials into products for a diverse set of markets in agriculture and supplements industry. Additives for polymers, Coatings and Sealants and biocides for industry, chemical additive suppliers into the PVC and polymers industries. Additives in the coatings, rubber, silicones and sealants markets and biocides for many other applications globaly. Aker Biomarine ASA Akvaren AS Contact: Kjetil Berge, R&D Director Fjordalleen 16, 250, OSLO, Norway M: +47 402 24 887 E: kjetil.berge@akerbiomarine.com W: www.akerbiomarine.com Contact: Sissel Stenberg, CEO Industriveien 2, 9062, FURUFLATEN, Norway M: +47 995 56 535 E: sissel@akvaren.no W: www.akvaren.no Products and technology, contract manufacturing and analytical services related to modified fatty acids (linoleic acid and omega3) intended for food and feed. Manufacturing plant at Sunnmøre. Collecting and storing fish waste as raw material for marine byproducts, e.g. feed for the aquaculture industry. Trading of marine byproducts (oil, fat, fish meal and flavours). AkzoNobel AlgaeCytes Ltd Contact: Tom Straw, R&D Manager Holland Park, Holland Drive, Newcastle upon Tyne, Tyne and Wear NE2 4LD T: +44 191 261 0237 E: tom.straw@akzonobel.com W: www.akzonobel.com AkzoNobel is the largest global paints and coatings company and a major producer of specialty chemicals. 22 Contact: Naz Bashir, CEO Discovery Park, Discovery Park House, SouthPod, Ramsgate Road, Sandwich, Kent CT13 9ND T: +44 1304 897626 M: +44 7879 810501 E: nazbashir@algaecytes.com W: www.algaecytes.com AlgaeCytes Limited is focused on developing and commercialising algae derived bioactive ingredients. The company has developed scalable demonstration units for the production of high value chemicals such as omega 3 oils from algae.
  • 11. Algea AS Contact: Tron Kjønnø, CEO Omagata 78, 6517, Kristiansund, Norway M: +47 917 41 801 E: tron.kjonno@algea.com W: www.algea.com Since 1937 Algea AS has been in industrial processing of bio raw material based on seaweed. Customers in more than 40 countries worldwide buy finished and semi-finished products based on plants from wild harvesting and aquaculture. Algenuity Contact: Andrew Spicer, Chief Research Scientist Eden Laboratory, Broadmead Road, Stewartby, Bedfordshire MK43 9ND T: +44 1234 765773 E: aps@algenuity.com W: www.algenuity.com Algenuity builds foundational technologies to support the emerging algal biotechnology industry. We bring together cutting edge molecular biology and genome engineering with outstanding engineering, electronics, software and product development capabilities to catalyse and propel the industry. Algipharma AS Contact: Arne Dessen, Executive Chairman Industriveien 33, 1337, SANDVIKA, Norway M: +47 951 70 278 E: arne.dessen@algipharma.com W: www.algipharma.com Development of new drugs based on marine polymers (from alginate polysachharide), focusing on developing medications and therapies in the areas of respiratory diseases (CF & COPD), wound healing and conditions caused by bacterial biofilms. Almac Group Limited Contact: Tom Moody, Head of Biocatalysis 20 Seagoe Indusrial Estate, Craigavon, Belfast, BT63 5QD T: +44 283 833 2200 E: tom.moody@almacgroup.com W: www.almacgroup.com Applied Enzyme Technology Ltd Contact: Guido Drago, Managing Director Monmouth House, Mamhilad Park, Pontypool, NP4 0HZ T: +44 1495 751 100 E: guido@gwent.org W: www.gwent.org Almac provides the most comprehensive range of services extending from research through pharmaceutical and clinical development to commercialisation of product. Applied Enzyme Technology Ltd (AET) is a company with core expertise in protein stabilisation. Application of our expertise and patented technology has resulted in the successful stabilisation of many enzymes spanning a wide variety of applications. Applikon Biotechnology UK Aqua Bio Technology ASA Contact: Glenn Robinson, UK Sales & Marketing Manager Basepoint Business Centre, Tewkesbury Business Park, Tewkesbury, Gloucestershire GL20 8SD T: +44 845 337 3306 E: glenn.robinson@applikon.co.uk W: www.applikon.co.uk Contact: Arvid Lindberg, CEO Thormøhlensgate 55, N-5008 Bergen, Norway T: +47 982 45 410 E: arvid@aquabiotech.no W: www.aquabiotechnology.com Applikon Biotechnology is a world leader in developing and supplying advanced bioreactor systems from laboratory scale to production scale. We are the only company that can take a customer from the initial screening stage up to full-scale production using the same platform. Developing and producing cosmetics and skincare products based on active marine ingredients, e.g. the protease zonase from hatching fluids of salmon having skin healing properties. Aquapharm Biodiscovery Ltd Aquazyme Technology AS Contact: Andrew Mearns-Spragg, Founder European Centre for Marine Biotechnology, Dunstaffnage, Oban, Argyll PA37 1QA T: +44 1631 559 393 E: andrew@aquapharm.co.uk W: www.aquapharm.co.uk Aquapharm is an innovative discovery company pioneering the development of new breakthrough products founded on the vast, untapped diversity of marine micro-organisms. Contact: Bernt Walther, Board member Lammanset, 5640, EIKELANDSOSEN, Norway M: +47 980 55 925 E: walther@mbi.uib.no Developing immuno stimulating compounds from salmon eggs. Initial applications related to inflammatory disorders or skin damage in veterinary medicine. 23
  • 12. A-Z LISTINGS Aragreen (UK) Ltd Contact: Jerome Vaughan, CEO Unit 6, Stowfield Business Park, Lydbrook, Gloucestershire GL17 9NG T: +44 1594 862888 E: jerome@aragreen.com W: www.aragreen.com Arctic Medical Nutrition AS Contact: Bjarte Langhelle, CEO 5501, Haugesund , Norway T: +47 52 85 94 80 E: info@arcticmedicalnutrition.no W: www.arcticmedicalnutrition.no Aragreen uses micro algae as a key building block for two distinct industrial processes (i) enhanced waste water treatment and (ii) the production of a range of algae containing anti-oxidants, pigments and proteins for human and animal consumption. Arctic Medical Nutrition AS is developing and commercializing branded consumer products and ingredients to the Health & Nutritional markets. The company has R&D laboratories located at the High-Technology Centre in Bergen, where the company’s R&D activities are carried out. ArcticZymes AS Associated British Foods (ABF) Contact: Olav Lanes, Head of R&D Sykehusveien 23, 9019, TROMSØ, Norway M: +47 47 41 42 56 E: ol@arcticzymes.com W: www.arcticzymes.com ArcticZymes is the Molecular Enzymes subsidiary of publicly listed Biotec Pharmacon. ArcticZymes develops and produces molecular grade recombinant enzymes, serving the molecular research and molecular diagnostics markets. Contact: Richard Morrison, Director of Corporate Development Western Centre, 10 Groves Street, London, W1K 4QY T: +44 20 7761 1203 E: richardmorrison@abfoods.com W: www.abf.co.uk Associated British Foods is a diversified international food, ingredients and retail group operating in 46 countries. AstraZeneca Contact: Keith Mulholland, Associate Principal Scientist Etherow T40/4, Pharmaceutical Development, AstraZeneca, Silk Road Business Park, Macclesfield, SK10 2NA T: +44 1625 517179 E: Keith.Mulholland@astrazeneca.com W: www.astrazeneca.com Biocatalysis Specialist in Chemical Sciences Avanticell Science Limited Contact: Colin Wilde, CSO GibbsYard Building, Auchincruive, Ayr KA6 5HW T: +44 1292 521060 E: info@avanticell.com W: www.avanticell.com Ayanda AS Contact: Jan Erik Angelsen, CEO Fridtjof Nansensplass 6, 9008, TROMSØ, Norway M: +47 930 30 544 E: jan.erik.angelsen@probio.no W: www.ayanda.com Provision of leading-edge products and services to clients in the pharmaceutical, agri-biotechnology and healthcare industries. Provision of leading-edge products and services to clients in the pharmaceutical, agribiotechnology and healthcare industries. Consumer ready pharmaceuticals and food supplements based on marine oils. Mainly omega-3 & Antioxidants Baxenden Chemicals BBI Solutions Contact: Falmai Binns, Research Associate Paragon Works, Baxenden, Accrington, Lancashire BB5 2SL T: +44 1254 872278 E: mail@baxchem.co.uk W: www.baxchem.co.uk Baxenden Chemicals is acknowledged as a global leader in polyurethane technology, supplying customers worldwide. 24 Contact: Mathew Willis, Sales Manager The Courtyard, 73 Ty Glas Avenue, Llanishen, Cardiff CF14 5DX T: +44 2920 747 232 E: info@bbisolutions.com W: www.bbisolutions.com BBI Solutions is a leading expert in immunoassay development and manufacturing services, and also provides an extensive portfolio of biological raw materials as well as nanoparticle and enzyme labels.
  • 13. Beocarta Ltd Contact: David Mousedale, Managing Director Royal College Building, 204 George Street, Glasgow, G1 1XW T: +44 1698 374501 E: dmousdale@beocarta.com W: www.beocarta.com Berg Lipidtech AS Contact: John O. Tørlen Sjukenesstranda 62, 6037, EIDSNES, Norway T: +47 70 19 92 00 E: john@blt.no W: www.blt.no/ Since 1985, beòcarta has worked on bioprocesses on industrial sites and in modern laboratories, seeking new solutions for old problems: how to make biomanufacturing more efficient and how to grow good science out of the laboratory and into a viable bio-economy. Supply food quality marine oils in bulk for the pharmaceuticals, health food and cosmetics industries Biobag International AS BioBullets Ltd Contact: Geir Løken, Sales Manager, Norway Hovsveien 8, 1832, ASKIM, Norway T: +47 69 88 85 90 E: geir@biobag.no W: www.biobag.no Contact: David Aldridge, Managing Director 2 Fitzhardinge Street, London, W1H 6EE T: +44 1223 338311 E: enquiries@biobullets.com W: www.biobullets.com Producing biodegradable plastic films from renewable sources BioBullets is an award winning company providing i) aquaculture enhancement products to increase growth rates and body condition of hatchery reared shellfish and ii) environmentally friendly control solutions for aquatic biofouling pests. Biocatalysts Ltd BioEnergy Services Ltd Contact: Stuart West, Managing Director Cefn Coed, Parc Nantgarw, Cardiff, CF15 7QQ T: +44 1443 843712 E: stuartw@biocats.com W: www.biocats.com Contact: Naz Bashir, Commercial Director Camburgh House, 27 New Dover Road, Canterbury, Kent CT1 3DN T: +44 7879 810501 E: nazbashir@bioenergysl.com W: www.bioenergysl.com Biocatalysts are a speciality enzyme manufacturer, toll manufacturer and consultancy company Bioenergy Services Limited (BESL) specialises in bringing together technical, market expertise and project management skills for the development and delivery of bioenergy solutions to enhance crop yields, liquid biofuels generation and providing economically sound renewable energy solutions. Biofortuna Ltd Bioinnovel Ltd Contact: Simon Douglas, CEO 1 Hawkeshead Road, Croft Business Park, Bromborough, Wirral CH62 3RJ T: +44 151 334 0182 E: simon.douglas@biofortuna.com W: www.biofortuna.com Contact: Joanna Vlahopoulou, Founder 32 Portland Terrace, Newcastle upon Tyne NE2 1QP T: +44 191 3757601 M: +44 7736 400231 E: enquiries@bioinnovel.com W: www.bioinnovel.com Freeze Dried Development and Production Service, Biofortuna offers its proprietary freeze-dried expertise and specially formulated cryopreservatives as an ISO13485 contract development and manufacturing service. Bioinnovel’s mission is to become a leading provider of innovative bioprocess optimal monitoring and control technologies (in line ultrasonic sensors for biomass monitoring with integrated process diagnostic software). Biolink Group AS Biomar AS Contact: Kåre Svaboe, CEO Hanav 4-6, 4327, SANDNES, Norway M: +47 951 43 485 E: kaare@biolink.no W: www.biolink.no Research and clinical documentation of pharmaceutical compounds based on anthocyanins and other polyphenols. Contact: Lars Myhra, CFO Bolstadveien 24, 8430, MYRE, Norway M: +47 915 55 707 E: lars.myhra@biomar.no W: www.biomar.no Mature company developing and manufacturing feed and feed ingredients for the aquaculture industry.Third largest supplier of feed for fishfarmers. 25
  • 14. A-Z LISTINGS Biome Technologies plc Contact: Paul Mines, CEO North Road, Marchwood Industrial Park, Marchwood, Southampton SO40 4BL M: +44 7917603519 E: paul.mines@biometechnologiesplc.co.uk W: www.biometechnologiesplc.com Biomega AS Contact: Kjartan Sandnes, Dir R&D Kontorsentret Austvoll, 5392, STOREBØ, Norway M: +47 416 63 965 E: kjartan.sandnes@marinebio.no W: www.marinebio.no The Group’s primary activity is the development of its bioplastics business. It is a UK champion in sourcing aromatic chemicals from lignin. Oil and bioactive peptides and protein hydrolysate isolated from marine sources BioPharma Technologies Ltd Biopolymer Solutions Contact: Kevin Ward, Director of R&D Biopharma House, Winnall Valley Road, Winchester, SO23 0LD T: +44 1962 841 092 E: btl@biopharma.co.uk W: www.biopharma.co.uk Contact: Sandra Hill, Managing Director Sutton Bonington Campus, Loughborough, LE12 5RD T: +44 115 9516146 E: info@biopolymersolutions.co.uk W: www.biopolymersolutions.co.uk BPS is a leading supplier of equipment to pharmaceutical, biotech and process industries in the UK, Ireland and France, with a specialisation in freeze drying technology and related equipment. Provide Scientific Services, Consultancy and Training to the Food, Pharmaceutical, Biomaterials and Ingredients sectors Biosentrum AS Bio-Sep Limited Contact: Arild Johannessen, CEO Prof Olav Hanssensv 15, 4021, STAVANGER, Norway M: +47 934 65 292 E: ajo@iris.no W: www.biosentrum.no Contact: Anthony McGarel-Groves, Company Secretary and Finance Director Clapton Revel, Wooburn Moor, Buckinghamshire HP10 9ND E: anthony@bio-sepltd.com W: www.bio-sepltd.com Contract manufacturing company for large scale fermentation of recombinant proteins Bio-Sep Limited is exploiting the use of surplus biomass for the production of ‘green sourced’ platform chemicals for a wide variety of industrial purposes using novel, carbon friendly technology. BioSyntha Technology Limited Biotec BetaGlucans AS Contact: Ann Kramer, CEO BioPark Hertfordshire, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX T: +44 1707 356133 E: ann.kramer@biosyntha.com W: www.biosyntha.com Contact: Ingrid Skjæveland Sykehusveien 23, Tromsø, Norway T: +47 77 64 89 00 E: is@biotec.no W: www.biotec.no BioSyntha is developing microbial technology to produce chemicals from renewable resources via fermentation of syngas. Biosyntha also offers bespoke research services in metabolic engineering, biocatalysis, fermentation and metabolite production. Biotec BetaGlucans AS, a wholly owned subsidiary of publicly listed Biotec Pharmacon, develops and manufactures immune modulating compounds for the human health sectors. Basic research on the mode of action of the various proprietary beta-1,3/1,6-glucan products at a cellular/molecular level has been the foundation for testing the products in animal models and in clinical trials. Biotec Pharmacon ASA Borregaard ASA Contact: Svein Lien, CEO Sykehusveien 23 Forskningsparken, 9294, TROMSØ, Norway M: +47 922 89 323 E: svein.lien@biotec.no W: www.biotec.no Discovery and manufacturing of bioactive compounds and enzymes from marine sources. Drug discovery program related to cancer. 26 Contact: Gudbrand Rørsrud, Technology Director Business Development Hjalmar Wessels vei 10, 1721, Sarpsborg, Norway M: +47 481 40 603 E: gudbrand.rodsrud@borregaard.com W: www.borregaard.com Borregaard operates one of the world’s most advanced biorefineries. By using natural, sustainable raw materials, the Group produces advanced and environmentally friendly biochemicals, biomaterials and bioethanol that replace oil-based products. Borregaard also holds strong positions in ingredients and fine chemicals.
  • 15. Boundless Horizons Ltd Contact: Alexander Bushell, Director (Innovation Centre, 189 Carver Drive, Kent Science Park, Sittingbourne, Kent ME9 8NP T: +44 1634 314287 E: info@boundlesshorizons.co.uk W: www.boundlesshorizons.co.uk Bouygues E&S Contracting UK Limited Contact: Doug Howard, Market Development Manager M: +44 (0) 7772 117764 E: doug.howard@bouygues-es.co.uk W: www.bouygues-es.co.uk Renewable energy horticultural crop growing systems Bouygues Energies & Services are a market leader in the provision of fully integrated world class multidisciplinary design and delivery solutions with a unique in-house delivery model for “first of a kind” specialist facilities within bio-industrial, bio-technology and bioscience market sectors. BP Biofuels Britest Ltd Contact: Graham Howes E: LynchT2@BP .com W: www.bp.com Contact: Charles Gordon, Senior Innovation Specialist The Heath Business & Technical Park, Runcorn WA7 4QX T: +44 1928 515683 E: charles.gordon@britest.co.uk W: www.britest.co.uk BP has a focused biofuels strategy, investing in the production of ethanol from sugarcane in Brazil, cellulosic feedstocks such as dedicated energy grasses in the US, and the development of the advanced fuel molecule biobutanol. Britest is a global leader in the development of innovative tools and methodologies to support process understanding and process design in the chemical and industrial biotechnology processing sectors. Brocklesby Ltd Building Research Establishment Contact: Robert Brocklesby, Managing Director Brocklesby House, Crosslands Lane, North Cave, Brough, East Yorkshire HU15 2PG T: +44 1430 424900 E: info@brocklesby.org W: www.brocklesby.org Contact: Alan Yates, Technical Director, Sustainablility Bucknalls Lane, Watford, WD25 9XX T: +44 1923 664000 E: enquiries@bre.co.uk W: www.bre.co.uk Brocklesby Ltd are recycling specialists of used cooking oil and fatty acids. We provide independent, third-party certification of fire, security and environmental products and services. Our status as a UKAS accredited laboratory reflects our competence and impartiality. Burdica Biomed Ltd Byotrol Contact: Kevin Burd, CEO 33 Research Avenue North, Edinburgh EH14 4AP T: +44 845 625 1044 E: kburd@burdica.com W: www.burdica.com Contact: Peter Dee Daresbury Science & Innovation Campus, Vanguard House, Keckwick Lane, Daresbury, WA4 4AB T: +44 1925 742 000 E: pdee@byotrol.com W: www.byotrol.co.uk Burdica Biomed Limited (BBL) is a fast-growing biotechnology and medical devices company. It is engaged in manufacturing and marketing of products based on the application of advanced biopolymers, and in research and development relating to biopolymer technologies. Byotrol is based on cationic biocides and hydrophobic polymers which are commonly used under European registration. Calanus AS Cambi AS Contact: Gunnar Rørstad, CEO Stakkevollvegen 65, P Box 2489 Langnes, 9272, TROMSØ, Norway .O. M: +47 913 65 942 E: info@calanus.no W: www.calanus.no Calanus AS is a Norwegian bio-marine company founded on competence on ecologically sustainable harvesting of the zooplankter Calanus finmarchicus and on scientific and technological expertise related to development, manufacture and use of health- and nutrition products and bioactive compounds based on this abundant resource present in the North Atlantic Ocean. Contact: Pål Jahre Nilsen, R&D Manager Skysstasjon 11 A, 1383, ASKER, Norway M: +47 992 91 277 E: paal.j.nilsen@cambi.no W: www.cambi.no Build and manage processing plants for biosolids and biowaste throughout the world. Uses a thermal hydrolysis technique to produce biogass and nutrients for farming. 27
  • 16. A-Z LISTINGS Cambridge Biopolymers Ltd Contact: Colin Chappell, Product Development, Composition & Legislation Ickleton Road, Duxford, Cambridge CB22 4FB T: +44 1223 832026 E: cgc@cambridge-biopolymers.com W: www.cambridge-biopolymers.com Cambridge Research Biochemicals Contact: Emily Humphrys, Commercial Director 10 Belasis Court, Belasis Hall Technology Park, Billingham, Cleveland TS23 4AZ T: +44 1642 567180 E: emily.humphrys@crbdiscovery.com W: www.crbdiscovery.com Cambridge Biopolymers develop and commercialise patented technology for the manufacture of thermosetting ‘bioresins’ made from plant oils. Cambridge Research Biochemicals, CRB, specialises in custom peptide and custom antibody production for research and industry. Campden BRI Cantab Biopharmaceuticals Contact: Steven Walker, Director General Station Road, Chipping Campden, Gloucestershire GL55 6LD T: +44 1386 842000 E: info@campdenbri.co.uk W: www.campdenbri.co.uk Contact: JimMills, CEO 155 Cambridge Science Park, Milton Road, Cambridge, CB4 0GN T: +44 1223 423 413 E: info@cantabbio.com W: www.cantabbio.com We provide technical support to the food, drinks and allied industries. We serve 2,000+ member companies and other clients in 65+ countries. Cantab Biopharmaceuticals Ltd is a biopharmaceutical company committed to the discovery and development of innovative drugs and drug formulations. Extensive experience in biopharmaceutical discovery, process development and GMP manufacturing to expedite the development of biosuperiors from inception through clinical development. Carbon Sequestration Ltd Cargill Contact: Norman Taylor, Director The Sheffield Bioincubator, 40 LeavyGreave Road, Sheffield S3 7RD T: +44 114 222 4555 E: info@carbondioxidesequestration.co.uk W: www.carbondioxidesequestration.co.uk Contact: Jon Halverson Guinness Road, Trafford Park, Manchester, M17 IPA T: +44 161 872 0225 E: jon_halverson@cargill.com W: www.cargill.co.uk CSL was originally set up by a team of scientists and business development professionals dedicated to the research and commercial optimisation of carbon sequestration technologies. Cargill is an international producer and marketer of food, agricultural, financial and industrial products and services. Founded in 1865, the privately held company employs 142,000 C-Cure Solutions CelluComp Contact: Tony Hutchings, Technical Director Alice Holt Lodge, Wrecclesham, Farnham, Surrey GU10 4LH T: +44 1420 526261 E: info@ccuresolutions.com W: www.ccuresolutions.com Contact: Eric Whale, Director, Founder & Head of Technology Unit 3, West Dock, Harbour Place, Burntisland, Fife KY3 9DW T: +44 1592 870335 E: eric.whale@cellucomp.com W: www.cellucomp.com C-Cure Solutions Limited offers a unique combination of contaminated land and ecology expertise. Our proprietary products are produced from renewable sources and provide a low carbon solution to contaminated land remediation. CelluComp is a dynamic new material science company based in Scotland that develops high performance products based on sustainable resources. Cellular Systems (Grantham) Limited Celtic Renewables Ltd Contact: Andrew Stacey, Founder T: +44 7802 888742 E: askandrew@cellsys.co.uk Cellular Systems is a consultancy working in the Bio Sciences. We currently have projects running in recovering valuable materials from food processing waste, early, predictive animal diagnostics, detection of diseases of high economic impact in agriculture and extended supply chain monitoring. 28 Contact: Martin Tangney, Founder & CSO Sighthill Campus, Edinburgh Napier University, Edinburgh EH11 4BN T: +44 131 455 3313 E: m.tangney@napier.ac.uk W: www.celtic-renewables.com Celtic Renewables Ltd is an innovative start-up company formed to commercialise a process for producing a superior next generation biofuel and other high value sustainable products, from the by-products of biological industries.
  • 17. Centre for Process Innovation (CPI-Wilton) Contact: Chris Dowle, Director of Sustainable Processing Wilton Centre, Witon, Recar TS10 4RF E: Chris.Dowle@uk-cpi.com W: www.uk-cpi.com Chemoxy International Limited Contact: David Randall, R&D Manager All Saints Refinery, Cargo Fleet Road, Middlesbrough, Cleveland TS3 6AF T: +44 1642 248555 E: david.randall@chemoxy.com W: www.chemoxy.com The Centre for Process Innovation is a UK-based technology innovation centre and part of the High Value Manufacturing Catapult. We use applied knowledge in science and engineering combined with state of the art facilities to enable our clients to develop, prove, prototype and scale up the next generation of products and processes. Chemoxy International serve many sectors from pharmaceutical, electronic and flavour & fragrance through to oil drilling, fuel additives and industrial solvent users. Our own products serve the paint and coatings sector. Chitinor AS Climostat Ltd Contact: Bjarte Langhelle , Commercial Director Postboks 193, 9387, Haugesund, Norway T: +47 52 85 94 80 E: info@chitinor.no W: www.chitinor.no Chitinor AS manufactures and supplies marine derived Health & Nutritional and Pharma & Personal Care ingredients. The Company has established a comprehensive know-how on extraction and processing of biopolymers from the Atlantic Ocean. Contact: Michael Fothergill, Director The Heath Business Park, Runcorn, Cheshire WA7 4QX T: +44 1928 515015 E: info@climostat.co.uk W: www.climostat.co.uk Climostat Ltd is developing technology to recycle CO2 from power plant flue gas emissions as valuable saleable products. Coressence Limited Contact: Richard Wood, CEO E: admin@coressence.co.uk Coressence is an emerging research-based, functional food ingredient, cosmetics and pharmaceutical company committed to developing innovative products based on the defined epicatechin composition and branded under the Evesse™ Trademark. Critical Processes Contact: Peter Hammond, MD Unit 2A, Brickyard Road, Roecliffe, North Yorkshire YO51 9NS T: +44 1423 325238 E: peter@criticalprocesses.com W: www.criticalprocesses.com Croda Europe Ltd Contact: Surinder Chahal, Research & Technology Director Foundry Lane, Widnes, Cheshire WA8 8UB T: +44 151 423 3441 E: surinder.chahal@croda.com W: www.croda.com Applied clean technology exploiting supercritical fluids and superheated water. Croda is a global manufacturer and supplier of speciality chemicals to a wide range of markets, including Personal Care, Health Care, Crop Care, Home Care, Polymer Additives, Coatings and Polymers, Lubricants and Geo-Tech. C-Tech Innovation Ltd C-Zero Contact: David Gardner, Managing Director Capenhurst Technology Park, Capenhurst, Chester, Cheshire CH1 6EH T: +44 151 347 2900 E: david.gardner@ctechinnovation.com W: www.ctechinnovation.com C-Tech Innovation provides a wide-ranging consultancy service designed to maximise your innovation and business opportunities. We help organisations to implement new processes and create new products; assist them in knowledge transfer and in commercialisation and business support. Contact: John Turvill, Director Nuneaton, Warwickshire T: +44 1242 545200 E: jturvill@czero.co.uk W: czero.co.uk Sustainable energy systems. 29
  • 18. A-Z LISTINGS Demuris Ltd Contact: Nick Allenby, Senior Bioscientist Newcastle Biomedicine Bio-Incubators, 1st floor William Leech Building, Framlington Place, Newcastle upon Tyne NE2 4HH T: +44 191 223 5608 E: nick.allenby@demuris.co.uk W: www.demuris.co.uk Desktop Genetics Ltd Contact: Edward Perello, Director London M: +44 7775770533 E: edwardp@deskgen.com W: www.deskgen.com Demuris is an antibiotic discovery company with unique and world leading expertise in key technologies of genome engineering, natural product sourcing and target-based screening. Provides biotechnology companies with software solutions to rapidly and accurately recycle existing DNA constructs into new goal DNA. Our products reduce reliance on external gene synthesis providers, eliminate the need to plan cloning protocols, and maximise organisational efficiency and corporate memory of internal gene constructs. DestiNA Genomics Dextra Laboratories Contact: Hugh Ilyine, CEO West Mains Road, Edingburgh EH9 3JJ T: +44 131 650 4821 E: hugh@destinagenomics.com W: www.destinagenomics.com Contact: Andy Hacking, Research Director Science and Technology Centre, Earley Gate, Whiteknights Road, Reading, Berkshire RG6 6BZ T: +44 118 935 7282 E: andy.hacking@dextrauk.com W: www.dextrauk.com DestiNA Genomics Ltd (DGL) is a University of Edinburgh spin-out company, formed to commercialise a revolutionary chemical based system for detecting nucleic acids and single nucleotide polymorphisms (SNP’s). The technology is unique and distinguishable from ALL existing enzymatic methods of nucleic acid analysis. Carbohydrate Synthesis and Analysis, the Dextra team are carbohydrate specialists with an international reputation in all areas of research, synthesis and analysis of carbohydrates and complex sugars. Diageo DNA Electronics Ltd Contact: Paul Walsh, CEO Lakeside Drive, Park Royal, London NW107HQ T: +44 20 8978 6000 E: info@diageo.com W: www.diageo.com Contact: Christofer Toumazou, CEO Ugli Campus Block C, 56 Wood Lane, London W12 7SB T: +44 20 7036 2100 E: contact@dnae.co.uk W: http://dnae.co.uk Diageo is the world’s leading premium drinks business with an outstanding collection of beverage alcohol brands across spirits, beer and wine DNA Electronics is creating a suite of electronic microchip-based solutions to enable faster, simpler and more cost-effective DNA analysis Dr Reddys DuPont Contact: David Chaplin, Head of R&D Chirotech Technology Centre, 410 Cambridge Science Park, Milton Road, Cambridge CB4 0PE T: +44 1223 728055 E: dachaplin@drreddys.com W: www.drreddys.com Contact: Frank DeGennaro, Manager Strategy & Business Development T: +1 302 892 7488 E: frank.degennaro@usa.dupont.com Dr Reddy’s is a global pharmaceutical company, headquartered in India. In Cambridge we specialise in using technologies including biocatalysis and chemocatalysis to make pharmaceutical intermediates and APIs. Through our knowledge of material science, we are providing safer, betterperforming, higher-quality, and more environmentally sustainable products in the global chemical industry to meet the needs of a growing world.construction to transportation and communications. Eisai Limited EKB Contact: Nick Burgin, Managing Director European Knowledge Centre, Mosquito Way, Hatfield, HertfordshireAL10 9SN T: +44 845 676 1400 E: info@eisai.co.uk W: www.eisai.co.uk Eisai is one of the world’s leading research-based pharmaceutical companies. 30 Contact: Michael Wright, Managing Director T: +44 1865 274591 E: mike.wright@ekbtechnology.com EKB Technology Ltd has recently been spun out from the University of Oxford to commercialise a revolutionary Bioprocessing Technology developed in conjunction with C-Tech Innovation Ltd.
  • 19. Eminate Ltd Contact: Rebecca McDowell, Project Manager Sutton Bonington Campus, Sutton Bonington, Leicestershire LE12 5RD T: +44 115 748 4130 E: rebecca.mcdowell@eminate.co.uk W: www.eminate.co.uk Ensus Contact: John Pinkney The Granary, 17a High Street, Yarm TS15 9BW T: +44 1642 794040 E: foodandfuel@ensusgroup.com W: www.ensusgroup.com Eminate specialises in sourcing ideas for new products and services and turning them into commercial reality. We reduce risk by developing novel ideas in partnership with representative customers before exiting. Our aim is to become a leading biorefiner of European cereal grains to produce greener food and fuel. Epax AS Epistem Ltd Contact: Iren Stoknes, R&D Manager Aarsætherveien 17, 6006, ÅLESUND, Norway M: +47 934 93 413 E: iren.stoknes@epax.com W: www.epax.com Contact: Saba Alzabin, Senior Inflammation Research Scientist 48 Grafton Street, Manchester M13 9XX T: +44 161 603 7731 E: s.alzabin@epistem.co.uk W: www.epistem.co.uk Global supplier of highly purified ultra-concentrated omega-3 ingredients for nutracuticals and international branded food products. Epsitem provides molecular biomarkers to measure drug-induced gene expression. Ewos AS Eximo AS Contact: Atle Kvist, CEO Tollbodallmenningen 1 B, 5004, BERGEN, Norway M: +47 905 43 500 E: atle.kvist@ewos.com W: www.ewos.com/no Contact: Jens Petter Jøstensen, CEO Roald Amundsens plass 1 C, 9008, TROMSØ, Norway T: 77621550 M: +47 482 59 279 E: jens.petter.jostensen@oddberg.no W: www.trofico.no The Norwegian branch of Cermaq’s R&D division. Active in various aspects of aquaculture R&D, including feed and fish health (mainly salmon). Feed ingredients and fine chemicals, e.g. phospholipids and DNA, from marine sources Farmaceutical Innovations Felleskjøpet Forutvikling AS Contact: Kevin Wall, Director Unit 2 Llanfair Workshops, Ffordd Caergybi, Llanfairpwllgwyngyll, Anglesey LL61 5SX T: +44 1248 208086 E: kevin.wall@farmaceuticals.biz W: www.farmaceuticals.biz Developing processes for the clean extraction of phytochemicals from sustainable sources. Contact: Knut Røflo, CEO Nedre Ila 20, 7018, TRONDHEIM, Norway M: +47 951 23 635 E: knut.roflo@fkf.no W: www.fk.no/forutvikling Developing new feed and feed ingredients for agricultural and pet markets. Felleskjøpet Rogaland Agder SA Contact: Stein Lima, R&D Director Sandvikveien 21, 4016, STAVANGER, Norway T: +47 51 88 73 17 E: stein.lima@fkra.no W: www.fkra.no Major producer of animal feed (livestock, pigs, chickens) and fertilizers. Photo supplied by Rothamsted Research 31
  • 20. A-Z LISTINGS Fine Organics Limited Contact: Simon Rowell, Commercial Director Seal Sands, Middlesborough TS2 1UB T: +44 8451 254251 E: simon.rowell@fineindustries.co.uk W: www.fineindustries.co.uk Fine Organics Limited is a UK based manufacturer of high quality fine chemicals, operating within three main market segments, Intermediates and Active Pharmaceutical Ingredients (APIs), Agrochemicals and Specialty Chemicals. Firmenich Bjørge Biomarin AS Contact: Karl Inge Slotsvik, CEO 6057, ELLINGSØY, Norway M: +47 905 86 047 E: karl.slotsvik@firmenich.com W: www.firmenich.com Flavour ingredients and Nutraceuticals extracted from marine sources. Part of the Swiss based company Firmenich. FMC Biopolymer AS Contact: Trond Helgerud, CEO Industriveien 33, 1337, SANDVIKA, Norway M: +47 971 64 465 E: trond_helgerud@fmc.com W: www.fmcbiopolymer.com Products based on alginate with main manufacturing plant in Haugesund and Drammen. Two business units within human and veterinary medicine, respectively Frutarom Contact: Steven Jackson, Technical Manager North Gare, Seaton Carew, Hartlepool TS25 2DT T: +44 1429 863555 E: sjackson@uk.frutarom.com W: www.frutarom.com Fujifilm Diosynth Biotechnologies Contact: Daniel Ozanne, Senior Business Development Manager Belasis Avenue, Billingham TS23 1LH T: +44 1642 363511 E: enquiries@fujifilmdb.com W: www.fujifilmdiosynth.com Frutarom creates, develops, manufactures and markets an extensive variety of high quality flavours and fine ingredients for customers in the food, beverage, functional food, flavour, fragrance, pharmaceutical, nutraceutical, and cosmetic industries. Fujifilm Diosynth Biotechnologies offers significant experience in the development and manufacture of recombinant proteins, vaccines and monoclonal antibodies, expressed in a wide array of microbial, mammalian and insect cell systems. FUJIFILM Imaging Colorants Ltd Geno SA Contact: Mark Kenworthy, Toxicology & Regulatory Affairs Manager PO Box 42, Hexagon Tower, Blackley, Manchester M9 8ZS T: +44 161 7211874 E: mark.kenworthy@fujifilmic.com W: www.fujifilm.eu Contact: Sverre Bjørnstad, CEO Holsetgata 22, 2317, HAMAR, Norway T: +47 950 20 600 M: +47 911 25 599 E: sb@geno.no W: www.geno.no FUJIFILM Imaging Colorants (FFIC) is a global leader in the development and supply of innovative, high performance colorants that are enabling new possibilities in digital print, and a range of specialty applications. Cooperative owned by 10.500 dairy farmers. Geno is also the globalization behind the internationally recognized live stock breed, Norwegian Red (NRF). The breeding program is based modern breeding technologies and artificial insemination. Genzyme GlaxoSmithKline Contact: Henry Featherstone, Public Affairs Director 4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford OX4 2SU T: +44 1865 405200 E: oxfordenquiries@genzyme.com W: www.genzyme.co.uk One of the world’s leading biotech companies, Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). 32 Contact: Joe Adams, SM Manager, Synthetic Biochemistry, Product Development Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY T: +44 1438 768605 E: joe.p.adams@gsk.com GSK is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. With our headquarters in the UK, we have a wide geographical reach.
  • 21. Glycomar Ltd Gradsol Ltd Contact: Charlie Bavington, Founder & Managing Director European Centre for Marine Biotechnology, Dunstaffnage Marine Laboratory, Dunbeg, Oban, Argyll PA37 1QA T: +44 1631 559 370 E: charlie@glycomar.com W: www.glycomar.com Contact: Gary Shepherd T: +44 7799 635283 E: gary.shepherd@gradsol.com Marine Biotechnlogy, GlycoMar is a biotechnology company developing products and services for the human healthcare and personal care markets. Gradsol is a sustainability consultancy practice within the renewables and environmental industry. Graminor AS Green Biologics Ltd Contact: Idun Christie, CEO Hommelstadvegen 60, 2322, RIDABU, Norway T: +47 991 64 846 E: idun.christie@graminor.no W: www.graminor.no Contact: Edward Green, Founder & CSO 45A Western Avenue, Milton Park, Abingdon, Oxfordshire OX14 4RU T: +44 1235 435712 E: info@greenbiologics.com W: www.greenbiologics.com The main plant breeding company in Norway supplying prebasic of cereals, oil crops, peas, grass and forrage crops, seed potatoes etc. Green Biologics Ltd. (GBL) is a leading industrial biotechnology company focused on the production of biobutanol and other C4 chemicals from various renewable feedstocks, including sugar, starch and cellulosic biomass. GW Pharmaceuticals Hebridean Seaweed Company Ltd Contact: Peter Gibson Porton Down Science Park, Salisbury, Wiltshire SP4 0JQ T: +44 1980 557000 E: info@gwpharm.com W: www.gwpharm.com Contact: Martin Macleod, Managing Director Arnish Point, Arnish Point Industrial Estate, Stornoway, Isle of Lewis HS2 9JY T: +44 1851 701255 E: martin@hebrideanseaweed.co.uk W: www.hebrideanseaweed.co.uk GW is developing a portfolio of cannabinoid medicines, of which the lead product is Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain and neuropathic pain. Hebridean Seaweed Company Limited is the largest industrial seaweed processor in Great Britain. The company manufactures seaweed products for use in the animal feed supplement, soil enhancement, alginate and nutraceutical sectors. Herboreal Ltd Hockley International Ltd Contact: Romain Viguier, Operations Manager 32/8 Hardengreen Industrial Estate, Dalhousie Road, Dalkeith EH22 3NX T: +44 131 663 3323 E: romain.viguier@herboreal.co.uk W: www.herboreal.com Contact: Frank Howard, Managing Director Hockley House, 3 Ashbrook Office Park, Longstone Road, Manchester M22 5LB T: +44 161 209 7400 E: mail@hockley.co.uk W: www.hockley.co.uk HERBOREAL LTD offers the largest range of naturally occurring Coumarins and Furocoumarins standards for analysis. We provide reference compounds to research institutes, food, cosmetics, pharmaceutical and biotechnology companies. Manufacturers and Exporters of products for Agricultural Crop Protection, Environmental Health, Animal Health and Application Equipment used in over 90 countries worldwide. Hofseth Biocare ASA Hyperthermics Holding AS Contact: Sjur Jessen, CEO Smuget 1, 1383, ASKER, Norway T: +47 66 76 55 60 W: www.hofsethbiocare.no Production of food and feed ingredients from marine biomass Contact: Harald Nordal, CEO Industriveien 42, 6160, HOVDEBYGDA, Norway M: +47 908 59 397 E: harald@greyston.no W: www.hyperthermics.com Proprietary thermophilic microbial strains from deep sea vents. 33
  • 22. A-Z LISTINGS Hypha Discovery Contact: Jonathan Steele, Research Director The Russell Building No.1, Brunel Science Park, Uxbridge, Middlesex UB8 3PQ T: +44 1895 814585 M: +44 7790 356823 E: jonathan.steele@hyphadiscovery.co.uk W: www.hyphadiscovery.co.uk InCrops Ltd Contact: Beatrix Schlarb-Ridley, Scientist University of East Anglia, NRP Innovation Centre, Norwich Research Park, Colney Lane, Norwich NR4 7GJ T: +44 1603 597248 M: +44 777 898 3612 E: b.schlarb-ridley@uea.ac.uk W: www.incropsproject.co.uk Hypha Discovery Limited is a leading natural products library company, specialising in the identification of novel, biologically active small molecules for pharmaceutical development. Hypha provides small molecule natural products discovery and production services to the pharmaceutical and agrochemical industries. InCrops is part of the Adapt Low Carbon Group, based at the University of East Anglia. Our team of expert business innovation managers work with businesses to commercialise new bio-renewable and low carbon products from alternative and non-food crop feedstock. INEOS Bio Ingenza Ltd Contact: New Technology R&D Manager T: +44 1324 493954 E: ian.little@ineos.com W: www.ineos.com Contact: Ian Fotheringham, President Wallace Building, Roslin BioCentre, Midlothian EH25 9PP T: +44 131 200 6355 E: ian.fotheringham@ingenza.com W: www.ingenza.com INEOS Bio’s advanced bioenergy technology takes wastes and sustainably turns them into advanced biofuel and renewable power. Ingenza provides efficient scalable bioprocesses to manufacture chemicals, biologics, pharmaceuticals and biofuels, from sustainable sources. Innospec Innovia Films Contact: Richard Dale, Operations Manager Oil Sites Road, Ellesmere Port, Cheshire CH65 4EY T: +44 151 355 3611 E: Richard.Dale@innospecinc.com W: www.innospecinc.com Contact: Andy Sweetman, Business Development & Sustainability Manager Wigton, Cumbria CA7 9BG T: +44 1697 342281 E: andy.sweetman@innoviafilms.com W: www.innoviafilms.com Innospec Specialty Chemicals is an international specialty chemicals company with approximately 900 employees in 20 countries and a turnover of $800 million. We divide our operations into three distinct business areas: Fuel Specialties, Performance Chemicals and Octane Additives. A leading global producer of speciality high performance Biaxially Oriented Polypropylene (BOPP) and Cellulose films for food packaging, tobacco overwrap and labels. Innu-Science International Flavours and Fragrances Inc (IFF) Contact: Nick Winstone, Managing Director Commodore House, Juniper Drive, London SW18 1TW T: +44 20 7979 7717 E: info@innu-science.co.uk W: www.innu-science.co.uk Contact: Tim Ridgway, R&D Manager Duddery Hill, Haverhill, Suffolk CB9 8LG T: +44 1440 715000 E: iffuk@iff.com W: www.iff.com Innu-Science UK is a subsidiary of Innu-Science Canada, biological cleaning products for industry and domestic use. Combining consumer understanding, innovative materials, and technology, our perfumers and flavorists elevate scents and tastes beyond base sensations to the level of unique experiences. Invista Isle Utilities Ltd Contact: Graham Aird, Intermediates R&D Manager The Wilton Centre, Redcar, Wilton, Cleveland TS10 4RF T: +44 1642 572200 E: graham.r.aird@invista.com W: www.invista.com IPT provides the resources and know-how to deliver world-scale technology for licensing to a growing portfolio of technologies in the value chains of polyester (PTA, polymer, fiber, R2R), polyurethane (BDO, PTMEG) and nylon (N2O abatement). 34 Contact: Fiona Griffith, Environmental Scientist PO Box 621, Epsom KT17 9JT T: +44 7875 446 657 E: Fiona.griffith@isleutilities.com W: www.isleutilities.com Isle Utilities is a technology and innovation consultancy specialising in cleantech. We have a proven track record in accelerating the development and commercialisation of emerging technologies through our Technology Approval Group (TAG), the industry forum that drives innovation.
  • 23. Johnson Matthey Contact: Liz Rowsell T: +44 118 9242239 E: rowsee@matthey.com W: www.matthey.com Keracol Limited Contact: Richard Blackburn, Founder School of Chemistry, University of Leeds, Leeds LS2 9JT T: +44 113 343 3757 E: technical@keracol.co.uk W: www.keracol.co.uk Johnson Matthey is a leading speciality chemicals company underpinned by science, technology and our people. A leader in sustainable technologies, many of our products enhance the quality of life for millions of people around the world Keracol develops novel approaches to the extraction of active molecules from plant sources for existing and novel applications. Our extracts are effectively applied in cosmetic products for hair coloration, hair care and skin care. KEW Royal Botanic Gardens Krüger Kaldnes AS Contact: Monique Simmonds, Director on Kew Innovation Unit Royal Botanic Gardens, Kew, Richmond, Surrey TW9 3AB T: +44 208 332 5328 E: m.simmonds@kew.org W: www.kew.org Contact: Kathrine Dursett, Market and Project Coordinator Hegnasletta 11, 3217, SANDEFJORD, Norway M: +47 414 05 963 E: kathrine.dursett@krugerkaldnes.no W: www.krugerkaldnes.no The Royal Botanic Gardens, Kew is one of the world’s leading plant and fungal science and conservation organisations. Through our work we aim to find plant-based solutions to global challenges such as biodiversity loss, food and water security, poverty, disease and changing climate. Supplier of technology and products for biologically based wastewater treatment. Applications related to oil&gass industry, aquaculture and medical manufacturing plants. KWS UK Ltd Leatherhead Food Research Contact: Hinrich Harling, Head R&D Services 56 Church Street, Thriplow, Nr Royston, Hertfordshire SG8 7RE T: +44 1763 207300 M: 49(5561)311652 E: h.harling@kws.de W: www.kws-uk.com Contact: Paul Berryman, CEO Randalls Road, Leatherhead, Surrey KT22 7RY T: +44 1372 376761 E: pberryman@leatherheadfood.com W: www.leatherheadfood.com KWS SAAT AG is one of the world’s four leading plant breeding companies, represented in more than 70 countries. Leatherhead Food Research delivers scientific research, global regulatory advice and market insights to the food and related industries. Works with Nordic companies on NPD, microbiology, nutrition, sensory and regulatory research. Lerøy Seafood Group ASA LGC Contact: Anders Tennefoss, Team Leader Value Added Products Bontelabo 2, NO-5003 Bergen, Norway T: +47 55213666 M: anders.tennefoss@leroy.no W: www.leroyseafood.com Contact: Maria Chisholm, Head of Commercial Development and Partnerships Queens Road, Teddington, Middlesex TW11 OLY T: +44 20 8943 8968 E: info@lgcgroup.com W: www.lgcgroup.com The leading exporter of seafood from Norway and the world’s second largest producer of farmed salmon and trout. LGC is an international leader in the delivery of measurement solutions, laboratory services, measurement standards, reference materials, genomics and proficiency testing. Lonza Biologics plc Lucite International Contact: Colin Lucas, Learning and Development Manager 228 Bath Road, Slough, Berkshire SL1 4DX T: +44 1753 777000 E: contact.slough@lonza.com W: www.lonza.com The Slough site is the center of excellence for mammalian biopharmaceutical process development and small-scale cGMP manufacturing. The site also specializes in offering a full range of analytical services, process scale-up activities and process optimization. Contact: David Johnson, Operations Manager Wilton Centre, Wilton, Redcar TS10 4RF T: +44 1642 447163 E: david.johnson@lucite.com W: www.luciteinternational.com Lucite International is the global leader in the design, development and manufacture of acrylic-based products. Our ICI and DuPont heritage is further strengthened by our current ownership by Mitsubishi Rayon Group. 35
  • 24. A-Z LISTINGS M Power World Ltd Contact: George Robertson, CFO Elvingston Science Centre, Near Gladsmuir, Tranent, East Lothian EH33 1EH T: +44 1875 408020 E: george.robertson@mpowerworld.co.uk W: www.mpowerworld.co.uk Marealis AS Contact: Jaran Rauø, CEO Forskningsparken, 9294, TROMSØ, Norway T: +47 909 81 162 E: jaran@marealis.no W: www.marealis.com MPowerWorld Ltd has developed a highly efficient bio-electrochemical system for purifying organic waste streams - whilst simultaneously generating electrical energy. Discovery and development of marine derived bioactive ingredients for health applications. Owned by Stella Polaris AS Marine Biopolymers Ltd Marine Harvest ASA Contact: David Mackie, Director Unit 54, Heathfield Industrial Park, Boundary Road, Ayr KA8 9DJ T: +44 1292 262680 M: +44 7595 024967 E: davidmackie12@btinternet.com W: www.marinebiopolymers.com Contact: Ole Eirik Lerøy, Chairman of the Board Sandviksboder 78A, 5035, BERGEN, Norway T: +47 21 56 23 00 M: +47 995 35 566 E: ole.eirik.leroy@marineharvest.com W: www.marineharvest.com Manufacturer of high value components extracted from brown seaweeds. Worlds leading seafood producer with operations in 22 countries. Marine Harvest Ingredients Maritex AS Contact: Bjørn Erik Flem, CEO 4130, HJELMELAND, Norway M: +47 920 24 515 E: bjoern.erik.flem@marineharvest.com W: www.marineharvest.com Contact: Toril Monsen Abelseth, CEO Havnegata 17, 8400, SORTLAND, Norway M: +47 917 37 406 E: tma@maritex.com W: www.tine.no Manufacturing omega-3 fatty acids and other ingredients. Daughter company of Marine Harvest, a major producer of fish filet and processed fish products for the consumer market. Wholly owned by TINE with R&D and production related to various marinebased chemicals, e.g. fish peptones and fish oils MedImmune UK Ltd MicroA AS Contact: Mike Austin, Senior Director - Site Operations Plot 6, Renaissance Way, Boulevard Industry Park, Speke, Liverpool L24 9JW T: +44 151 485 7700 E: austinm@medimmune.com W: www.medimmune.com Contact: Svein Dahle, CEO Oljevegen 4, 4056, TANANGER, Norway M: +47 905 91 583 E: sd@priforsk.no W: www.microa.no MedImmune is the worldwide biologics business for the AstraZeneca Group. UK facilities include vaccine manufacturing operations in Speke and antibody discovery and research laboratories in Cambridge. Proprietary reactor technology for cultivation of autotrofic microalgae. Microbial Developments Ltd Modern Water plc Contact: Tim Nelson Spring Lane North, Malvern Link, Worcestershire WR14 1BU T: +44 1684 891055 E: info@micdev.com W: www.microbialdevelopments.com Microbial Developments Limited has 15 years experience in the manufacture of m icro-organisms, exporting to 47 countries across the globe. 36 Contact: Anna Whittaker, Sales Manager Europe Bramley House, The Guildway, Old Portsmouth Road, Guildford GU3 1LR T: +44 1483 696000 E: info@modernwater.co.uk W: www.modernwater.com Modern Water’s Monitoring division has developed some of the world’s most advanced systems for monitoring water quality. The Monitoring division provides market-leading toxicity monitoring systems, trace metal and environmental monitoring systems.
  • 25. Mylnefield Research Services Contact: Jonathan Snape, Commercial Director Invergowrie, Dundee DD2 5DA T: +44 1382 568568 E: jsnape@mrsltd.com W: www.mrsltd.com N3 Pharma AS Contact: Jørgen Blikra Lødemel, CEO Fr. Nansensplass 6, 9008, TROMSØ, Norway M: +47 413 38 866 E: jorgen.lodemel@noromega.no W: www.probio.no The remit of MRS remains unchanged, to undertake contract research, especially plant breeding, license plant varieties internationally and deliver analytical services. Profits made by MRS will be gift aided to the James Hutton Institute. Discovery and development of arctic nutrients and ingredients, particularly marine lipids. Owned by Probio ASA. Nattopharma ASA Navamedic ASA Contact: Hogne Vik, CEO Kirkeveien 59B, 1363 Høvik, Norway T: +47 40 00 90 08 E: info@nattopharma.com W: www.nattopharma.com Contact: Olof Milveden, CEO Box 107, 1325, LYSAKER, Norway T: +47 67 11 25 40 E: firma@navamedic.com W: www.navamedic.com Develops and manufactures vitamin K2 extracted from natto, soybeans fermented by Bacillus subtilis. Develops and markets pharmaceutical product for osteoarthritis (OA) based on glucosamine HCl, a marine biproduct from shrimps. NCIMB Nergård AS Contact: Samantha Law, Deputy Curator Ferguson Building, Craibstone Estate, Aberdeen AB21 9YA T: +44 1224 711100 E: s.law@ncimb.com W: www.ncimb.com A microbiology and chemical analysis company that houses the biggest reference collection of microorganisms in the UK. An International Depository Authority (IDA) for organisms that are the subject of patent applications. Contact: Tommy Torvanger, CEO or Arne E. Karlsen, CFO Strandgata 9, NO-9008, Tromsø, Norway T: +47 900 98 691 M: +47 901 60 635 W: www.nergard.no Integrated fishery group whose business activities includes catching, processing and sales. Supplier of seafood from pelagic fish ( e.g. herring, capelin and mackerel) and whitefish ( e.g. cod, haddock and saithe). New Horizons Global Limited Contact: Stephen Chestnutt, CEO Penrhyn Road, Business Park South, Liverpool, Merseyside L34 9HY T: +44 151 632 8104 E: stephen.chestnutt@newhorizonsglobal.com New Horizons Global Ltd continues to explore innovative areas of Science and Technology for commercialization, and employs or is in contract with a range of individuals including Scientists, Micro biologists, Molecular biologists, Researchers, Engineers, Computer and Technology professionals, Marketing and Sales and many more. NiTech Contact: Xiong-Wei Ni, Founder & Director 10 Cammo Place, Edinburgh EH4 8EN M: +44 7795096838 E: xiongwei.ni@nitechsolutions.co.uk W: www.nitechsolutions.co.uk NiTech is focused on helping companies to improve their competitiveness, whether this is through greater innovation, lowering cost of production, or delivering significant improvements through the supply chain. Nordlaks AS Contact: Inge Berge, CEO Industriveien 13, 8450, STOKMARKNES, Norway T: +47 76 11 81 00 E: inge.berg@nordlaks.no W: www.nordlaks.no Major producer of farmed salmon and trout. Food consumer products as well as by-products/ingredients. 37
  • 26. A-Z LISTINGS Norilia AS Contact: Morten Sollerud, CEO Lørenveien 38, 513, OSLO, Norway M: +47 900 55 373 E: morten.sollerud@norilia.no W: www.norilia.no Focus on opportunities in by-products from livestock. Norsk Protein AS Contact: Lars Aashammer, CEO Smiuhagen 25, 2323, INGEBERG, Norway M: +47 913 91 977 E: lars.aashammer@norskprotein.no W: www.norskprotein.no/ Major company exploiting by-products from livestock and poultry production for ingredients and bioenergy. 5 processing plants in Norway. Norsvin SA Contact: Olav Eik-Nes, CEO Furnesvegen 223, 2319, HAMAR, Norway M: +47 951 09 167 E: olav.eik-nes@norsvin.no W: www.norsvin.no Farmers co-operative focusing on breeding of pigs. Pedigree registers and production of active semen and genetic material. R&D through several daughter companies: Geninova AS, Team Semin AS, Biobank AS. Nortura SA Lørenveien 37, 585, OSLO, Norway W: www.nortura.no NovaBiotics Contact: Derry Mercer, Principal Scientist Cruickshank Buildings, Craibstone, Aberdeen AB21 9TR T: +44 1224 711377 E: info@novabiotics.co.uk W: www.novabiotics.co.uk Main farmers cooperative organisation for Norwegian meat and poultry production. NovaBiotics Ltd is a clinical-stage speciality biotechnology company focused on the application of first-in-class anti-infective technology for difficult-to-treat, medically unmet fungal and bacterial conditions. Novacta Biosystems Ltd Novozymes Biopharma UK Ltd Contact: Mike Dawson, CSO Biopark Hertfordshire, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX T: +44 1707 356130 E: mike.dawson@novactabio.com W: www.novactabio.com Contact: Thomas Videbaek, Business Development Director Mabel Street, Nottingham NG2 3ED T: +44 115 955 3300 E: info@novozymes.com W: www.biopharma.novozymes.com Novacta is a clinical stage biopharmaceutical company discovering, developing and commercialising innovative drugs for the treatment of bacterial infections, especially those caused by drug resistant bacteria. Novozymes is a biotech company with a strong focus on enzyme production. We are committed to changing the very foundations of our industrial system for the better by using industrial biotechnology. Novus Biologicals Nutrimar AS Contact: Andy Walker, European Manager 12 Cambridge Science Park, Cambridge CB4 0FQ T: +44 1223 426001 E: andy@novusbio.com W: www.novusbio.com The mission of Novus Biologicals, LLC is to accelerate scientific discovery by developing and marketing unique products for the lifesciences. 38 Contact: Kristbjørn Bjarnason, CEO 7266, Kverva, Norway M: +47 469 05 385 E: kb@nutrimar.no W: www.nutrimar.no Produces food grade quality marine oils and protein extracts from salmon.
  • 27. Nzomics Biocatalysis Contact: Justin Perry, Commercial Director Ellison Building, Newcastle upon Tyne NE1 8ST T: +44 191 227 3550 E: nzomics@northumbria.ac.uk W: www.nzomics.com Omniceutica Ltd Contact: Janet Worrell, Production Manager Unit 14, Asfordby Business Park, Melton Mowbray, Leicestershire LE14 3JL T: +44 1664 810354 E: info@omtca.com W: www.omtca.com Nzomics Biocatalysis offers products, services and expertise to those companies looking to use biocatalysis in a post-genomic era. This presents opportunities for R&D teams to exploit state of the art advances in enzyme production and optimization. Omniceutica offers a contract product development and pilot scale manufacturing service to the pharmaceutical and the food and drink industries. Oxford Catalysts Oxford Nanopore 115e Olympic Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SA T: +44 1235 841700 E: info@oxfordcatalysts.com W: www.oxfordcatalysts.com Contact: Gordon Sanghera, CEO Edmund Cartwright House, 4 Robert Robinson Avenue, Oxford Science Park, Oxford OX4 4GA T: +44 845 034 7900 E: info@nanoporetech.com W: www.nanoporetech.com Oxford Catalysts Group PLC is the leading technology innovator for clean synthetic fuel production. Oxford Nanopore Technologies is developing the GridION system and miniaturised MinION device. These are a new generation of electronic molecular analysis system for use in scientific research, personalised medicine, crop science, security/defence and more. Oxyrane Paper and Fibre Research Institute (PFI) Contact: Jev Binns, Financial Director Greensheys, Manchester Science Park, 10 Pencroft Way, Manchester M15 6JJ T: +44 161 227 8887 E: info@oxyrane.com W: www.oxyrane.com Contact: Philip André Reme, Director Høgskoleringen 6B, 7491, TRONDHEIM, Norway W: www.pfi.no Oxyrane develops enzyme replacement therapies (ERTs) for the treatment of lysosomal storage diseases (LSDs) - where an inherited, deficient enzyme leads to undesired cellular waste accumulation and disease. PFI is an independent research institute within wood fibre, pulp, paper and new biobased chemicals, materials and biofuels (biorefinery processes). PFI is a subsidiary of INNVENTIA AB, an internationally leading Swedish R&Dcorporation. Pentagon Fine Chemicals Pfizer Contact: Alister Lloyd, Commercial Director Lower Road, Halebank, Widnes, Cheshire WA8 8NS T: +44 151 422 3244 E: alloyd@pentagonchemicals.co.uk W: www.pentagonchemicals.co.uk Contact: Alan Pettman, Senior Research Fellow Discovery Park, Sandwich, Kent T: +44 1304 644040 E: alan.pettman@pfizer.com W: www.pfizer.co.uk Pentagon is a leading UK based chemical manufacturer of organic intermediates for use in the life science, petrochemical, and speciality chemicals markets. Pfizer Worldwide R&D – Advancing Medicines and Vaccines Pharma Marine AS Phytopharm PLC Contact: Leif Kjetil Gjendemsjø, CEO Terøya, 6280, SØVIK, Norway M: +47 92609960 E: leif@pharmamarine.no W: www.pharmamarine.com Produced highly concentrated DHA Omega-3 as by-products from calamari. Contact: Tim Sharpington, CEO Lakeview House, 2 Lakefield Court, Ermine Business Park, Huntingdon PE29 6UA T: +44 1480 437697 E: info@phytopharm.com W: www.phytopharm.com Phytopharm plc is a development stage pharmaceutical Group developing novel treatments targeting diseases with high levels of unmet need, with the objective of developing products to key value inflection points before seeking late-stage development and/or commercial partners. 39
  • 28. A-Z LISTINGS Phytoquest Contact: Robert Nash, Managing Director Plas Gogerddan, Aberystwyth, Ceredigion SY23 3EB T: +44 1970 823200 E: robert.nash@phytoquest.co.uk W: www.phytoquest.co.uk Phytovation Ltd Contact: Andrew Beggin, CEO Units 8&9 Zone 6, Cibyn Industrial Estate, Caernarfon, Gwynedd LL55 2BD T: +44 1286 671666 E: andrewbeggin@phytovation.co.uk W: www.phytovation.co.uk PhytoQuest owns science to innovate natural ingredients and compounds in the high-margin healthy-living products emerging from the convergence of food, pharmaceuticals, and cosmetics. Phytovation is a young company, located in North West Wales, dedicated to the production of high quality plant extracts for use in the pharmaceutical and allied industries. Piramal Healthcare Plant Bioscience Limited (PBL) Contact: Bob Holt, Research Director Biocatalysis R435, The Wilton Centre, Redcar, Cleveland TS10 4RF T: +44 1642 438 122 E: robert.holt@piramal.com W: www.piramal.com Contact: Tracy Benttinson, Corporate Affairs Norwich Research Park, Colney Lane, Norwich, Norfolk NR4 7UH T: +44 1603 456500 E: rjm@pbltechnology.com W: www.pbltechnology.com Pharmaceutical contract manufacturer specializing in the development and application of enzyme catalysis in organic synthesis. Plant Bioscience Limited (PBL) is an independent technology management company specialising in plant, food and microbial science. Our services are available to any researcher or research organisation that is seeking assistance and advice with protecting and commercialising new technology. Plastid AS Plaxica Contact: Rosalind Russell, CEO Hanav 4-6, 4327, SANDNES, Norway M: +47 924 69 096 E: rosalind.russell@plastid.no W: www.plastid.no Production of high value recombinant proteins from genetically engineered plants Contact: Ed Marshall, Head of Research Level 1, Bessemer Building, Imperial College, London SW7 2AZ T: +44 207 594 3575 E: info@plaxica.com W: www.plaxica.com Plaxica’s technology allows high performance polylactic acid (PLA) to replace traditional polymers produced from oil. It enables the manufacture of a range of PLA polymers and intermediates, important as replacements for today’s petrochemical products as part of a more sustainable future. Plymouth Marine Laboratory (PML) Applications Contact: Mike Allen T: +44 1752 633100 PML Applications provides you with access to over 30 years of expertise in international marine research. We work with developers, manufacturers and end-users on issues related to ballast water management, biofouling, marine renewables, bubble columns (algae growth techniques) and biodiscovery. Polytherics Contact: John Burt, CEO The London Bioscience Innovation Centre, 2 Royal College Street, London NW1 0NH T: +44 207 691 3580 E: info@polytherics.com W: www.polytherics.com PolyTherics provides a range of proprietary technologies to enable the development of better biopharmaceuticals. 40 Procarta Biosystems Ltd Contact: Michael McArthur, CSO & Director Norwich Bio-Incubator, Norwich Research Park, Colney Lane, Norwich NR4 7UH T: +44 1603 450960 E: info@procartabio.com W: www.procartabio.com Procarta Biosystems is developing a new class of DNA-based therapeuticals, snare™ antibacterials, capable of combating drug-resistant bacterial infections. snare™ antibacterials act on novel genomic targets by capturing key regulatory proteins to block essential bacterial genes and defeat infection.
  • 29. Procter & Gamble Contact: Elena Lurie-Luke, P&G Open Innovation & Global Bioscience Business Development London Innovation Centre, Whitehall Lane, Egham TW20 9NW T: +44 1784 474900 E: lurieluke.e@pg.com W: www.pg.com Promar AS Contact: Audun Goksøyr, CEO Snarøya 57, 1367, SNARØYA, Norway M: +47 920 22 201 E: ag@intravision.no W: www.intravision.no P&G is the world’s largest consumer goods company and a leading innovation investor in its category, with operations in 75 countries, brands sold in 180 countries, and over 8,000 R&D experts located around the globe. Supplier of light system for microalgae cultivation. Pronova Biopharma ASA Protein Technologies Ltd Contact: Gunnar Berge, Dir Bus Dev Vollsveien 6, 1366, LYSAKER, Norway M: +47 901 04 306 E: gunnar.berge@pronova.com W: www.pronova.com Contact: Paul Goddard, CEO Williams House, Manchester Science Park, Llyod Street North, Manchester M15 6SE T: +44 161 226 2366 E: info@protein-technologies.com W: www.protein-technologies.com Global leader in omega-3 based health care products, including prescription drugs (Omacor), dietary supplements and clinical nutrition. HQ in Norway. Recently acquired by BASF. PTL has the necessary skills and a full, in-house suite of equipment for the production of all types of recombinant proteins from gene design to protein production to biophysical characterization. Prozomix Limited Robinson Brothers Limited Contact: Simon Charnock, Business Development Station Court, Haltwhistle, Northumberland NE49 9HN T: +44 1434 400455 E: simon.charnock@prozomix.com W: www.prozomix.com Contact: Adrian Hanrahan, Business Development Pheonix Street, West Bromwich, West Midlands B70 0AH T: +44 121 553 2451 E: amhanrahan@rbltd.co.uk W: www.rbltd.co.uk Prozomix Limited is a privately owned research orientated UK biotechnology company that develops, produces and supplies a large, diverse and rapidly expanding range of novel enzymes and related advanced products and services for Biocatalysis and other focus areas, such as Biofuels and the Biorefinery. Established in 1869, we are today one of the UK’s largest independent manufacturers of speciality organic chemicals. Roslin Cells Ltd SABMiller Contact: Jonny McMichael, New Business Manager Scottish Centre for Regenerative Medicine, 5 Little France Drive, Edinburgh EH16 4UU T: +44 131 658 5189 E: info@roslincells.com W: http://roslincells.com Contact: Francis Bealin-Kelly, Corporate Affairs SAB Miller House, Church Street West, Woking, Surrey GU21 6HS T: +44 1483 264000 E: info@sabmiller.com W: www.sabmiller.com Roslin Cells is a world leader in the development and manufacture of cell therapies and pluripotent stem cells for applications in research, drug discovery and therapy. We’re one of the world’s leading brewers, operating across six continents Sasol Scanbio AS Contact: Carl Fredrik Eide, CEO Contact: Ronan Bellabaraba, Principal Scientist W: www.sasol.com Sasol is an international integrated energy and chemical company that leverages the talent and expertise of our more than 34 000 people working in 38 countries. Stiklestadveien 1, 7041, TRONDHEIM, Norway T: +47 73 99 21 70 M: +47 924 15 015 E: carl.eide@scanbio.com W: www.scanbio.com Producing protein hydrolysate and oil from fish waste. 41
  • 30. A-Z LISTINGS Scandiderma Contact: Geir Håvard Kvalheim, CEO Sykehusveien 23, 9294, TROMSØ, Norway M: +47 908 59 214 E: geir@scandiderma.com W: www.scandiderma.com Scotmas Group Contact: Alistair Cameron, Microbiologist Spylaw Road, Kelso, Borders, Scotland TD5 8DL T: +44 1573 226901 E: alistair@scotmas.co.uk W: www.scotmas.com Development and manufacturing of cosmetics and products for skin care based on marine natural compounds. Best known for our extensive range of chlorine dioxide systems, developed with over 25 years experience in the market, we are now actively involved in developing microbial biotechnology, insect repellents, insecticidal textiles and consumer product ingredients. Scottish Bioenergy Seagarden AS Contact: David Van Alstyne, Chief Executive Hillhead-Kirkside, St. Cyrus, Scotland DD10 0DA T: +44 1674 850061 E: info@scottishbioenergy.com W: www.scottishbioenergy.com Contact: Bjarte Langhelle, Commercial Director Karmsund Fiskerihavn, 4262, Avaldsnes, Norway T: +47 52 85 94 80 E: info@seagarden.no W: www.seagarden.no Scottish Bioenergy was founded in 2007 with the objective of making biofuels from algae. The company has licensed patent pending systems and methods of biofuel production using novel bioreactors and refining systems. Seagarden AS is producing and supplying Seafood Ingredients and marine Health & Nutritional Ingredients. The Company has built a reputation as a supplier of high quality marine ingredients through several years of international presence. The product portfolio consists of more than 50 commercial product varieties, used as ingredients in consumer food products. Seagarden ASA Seaweed Energy Solution AS Contact: Bjarte Langhelle, Commercial Director Postbox 193, 5501, HAUGESUND, Norway T: +47 52 85 94 80 E: info@seagarden.no W: www.seagarden.no Contact: Pål Andreas Bakken, CEO Havnegaten 9 Pirsenteret, 7462, TRONDHEIM, Norway M: +351 967 477 563 E: bakken@seaweedenergysolutions.com W: www.seaweedenergysolutions.com Seagarden ASA is the holding company of the Seagarden group. The Company acts in three international business and market areas; Seafood Ingredients, Health & Nutrition and Pharma & Personal Care. Seagarden is a producer of natural biomarine ingredients and consumer products. Cultivation, harvesting and processing of seaweed for biorefining. Senjabio AS SERE-Tech Innovation Ltd Contact: Karl Kristian Eilertsen 9389, HUSØY, Norway M: +47 928 99 777 E: karl@senjabio.no W: www.senjabio.no Contact: Narinder Bains, Director E: narinder.bains1@btinternet.com Startup focusing on marine by-products. Servier Laboratories Limited Contact: Sarah Jane Brennan, R&D Rowley, Wexham Springs, Slough, Berkshire SL3 6PJ T: +44 1753 662744 E: sarah-jane.brennan@uk.netgrs.com W: www.servier.co.uk The Group’s key goal, the discovery of innovative drugs and their development for use by the worldwide healthcare community, is a long-term undertaking marked by challenges that are scientific, human, industrial and financial. 42 Shell Global Solutions Contact: Jeremy Shears, Manager Biodomain Shell Technology Centre Thornton, PO Box 1, Chester, Cheshire CH1 3SH T: +44 151 373 5000 E: J.Shears@shell.com W: www.shell.com We are committed to responsible energy, innovative technology solutions and environmentally friendly approaches. Our technologies have been developed in response to the challenges that emerge when operating complex process plants in demanding operating environments.
  • 31. Skretting Aquaculture Research Centre AS Contact: Alex Obach, CEO Sjøhagen 3, 4016, STAVANGER, Norway M: +47 918 28 021 E: Alex.Obach@skretting.com W: www.skretting.com Smartfish AS Contact: Janne S. Mathisen, R&D Director Gaustadalléen 23, 373, OSLO, Norway M: +47 932 08 702 E: janne@smartfish.no W: www.smartfish.no Global supplier of aquaculture feed. Market health drinks with omega-3 fatty acids from salmon based on proprietary emulsion method. Medical effect being studied in clinical trials. Solvert Ltd Statoil ASA Contact: Kris Wadrop, CEO The Wilton Centre, Wilton, Recar, Cleveland TS10 4RF T: +44 7870 802492 E: kris.wadrop@solvertltd.co.uk W: www.solvertltd.co.uk Contact: Børre Tore Børresen Forusbeen 50, 4035, STAVANGER, Norway M: +47 41611582 E: btbo@statoil.com W: www.statoil.com Solvert has developed technology to produce renewable chemicals from waste biomass. Using waste biomass diverted from landfill Solvert can produce chemicals such as n-butanol, acetone, hydrogen and lactic acid. Statoil is an international energy company with operations in 35 countries, building on 40 years of experience from oil and gas production on the Norwegian continental shelf. Several R&D activities related to biofuel and biocatalytic conversion. Stiftelsen Dey Norske Skogfrøverk Stratophase Contact: Øyvind Meland Edvardsen, CEO Birkebeinerv 11, 2316, HAMAR, Norway M: +47 995 11 266 E: oyvind@skogfroverket.no W: www.skogfroverket.no Contact: Sam Watts, Technical Business Development Director Unit 10a The Quadrangle, Premier Way, Romsey, Hampshire SO51 9DL T: +44 1794 511226 E: sam.watts@stratophase.com W: www.stratophase.com The Norwegian Forest Seed Center is a seed bank and a commercial provider of seeds. Stratophase products monitor nutrient status, with optical microsensors, to enable real-time continuous control. Biomanufacturers are then able to constantly refine and manipulate fermentation bioprocesses, to improve yields and consistency of product, and avoid the costs of wastage in biopharmaceutical manufacture. Sun Chemical Synthace Limited Contact: Rudi Lenz, President & CEO Wrexham Springs, Framewood Road, Slough, Berkshire SL3 6PJ T: +44 203 139 0000 E: info@sunchemical.com W: www.sunchemical.com Contact: Laurent Malivert, Principal Scientist The London Bioscience Innovation Centre, 2 Royal College Street, London NW1 0NH T: +44 207 554 5877 E: info@synthace.com W: www.synthace.com An industry leader - Sun Chemical, the world’s largest producer of printing inks and pigments, is a leading provider of materials to packaging, publication, coatings, plastics, cosmetics and other industrial markets. Synthace Limited is the UK’s first dedicated synthetic biology company, spun out of University College London in January 2011, based on a platform technology for the rapid engineering and optimization of complex biological processes. Synthomer Limited TATA Chemicals Europe Contact: Pete Shaw, CSO Central Road, Templefields, Harlow, Essex CM20 2BH T: +44 1279 436211 E: info@synthomer.com W: www.synthomer.com/ Synthomer is one of the world’s major suppliers of latices and speciality emulsion polymers supporting leadership positions in many market segments including coatings, construction, textiles, paper and synthetic latex gloves. Contact: Cyrus Mistry, Chairman Mond House, Winnington Lane, Northwich, Cheshire CW8 4DT T: +44 1606 724000 E: sales-tcel@tatachemicals.com W: www.tatachemicals.com/europe/ Tata Chemicals Europe is one of the world’s leading manufacturers of soda ash and associated alkaline products, with manufacturing operations in Cheshire, UK. Soda ash is a vital constituent in a wide range of manufacturing processes including those for glass, detergents and industrial chemicals. 43
  • 32. A-Z LISTINGS TBAT Innovation Limited Contact: Matt Symonds, Director Lockington Hall, Lockington, Derby, DE74 2RH T: +44 1509 670610 E: matts@tbat.co.uk W: www.tbat.co.uk TerraVerdae Bioworks Contact: William Bardosh, CEO Centre for Process and Innovation, Suite J2, Wilton, Redcar TS10 4RF E: info@terraverdae.com W: www.terraverdae.com TBAT Innovation is a consultancy assisting organisations to develop products/technologies/solutions by enabling access to funding and partners and providing technology and market insight. Our novel bioprocess converts C1 feedstocks including waste-derived methanol into bioplastics and industrial metabolites. We also offer high efficiency protein expression, metabolic engineering and bioprocess development services. The Food and Environment Research Agency (FERA) Tine SA Contact: Elaine Fitches, Senior Molecular Biologist/Biochemist Sand Hutton, York YO41 1LZ T: +44 1904 462564 E: elaine.fitches@fera.gsi.gov.uk W: www.fera.defra.gov.uk/scienceResearch/specialInterestGroups/ biorenewables Contact: Johanne Brendehaug, R&D Director Dronning Eufemias gate 6, 191, OSLO, Norway M: +47 915 95 136 E: ‘johanne.brendehaug@tine.no’ W: www.tine.no We are a small group of scientists interested in a diverse range of topics concerned with the valorisation of waste. Current areas of particular interest include optimisation of anaerobic digestion; risk appraisal for sludge treatment processes; novel fermentation products from food waste and insect biotechnology. Major farmers cooperative for dairy products. TL Science Limited TMO Renewables Ltd Contact: Simon Thain, Managing Director Unit 3b, Wick, Caithness, Scotland KW1 4YR T: +44 1955 611385 M: +44 7801438719 E: simon.thain@thainlab.co.uk W: www.thainlab.co.uk Contact: Kirstin Eley, Head of technical Development 40 Alan Turing Road, Surrey Research Park, Guildford, Surrey GU2 7YF T: +44 1483 303305 E: keley@tmo-group.com W: www.tmo-group.com Research and consultancy services for Identification and quantification for natural compounds, Food and product chemical and toxin testing, Metabolite analysis, Biomarker discovery programmes, and Bioenergy & biofuel chemistry characterisation. TMO is ideally placed to provide value added integrated solutions to the challenges of waste management, converting low value waste into high demand, high value energy products. Unilever Vectron Biosolutions AS Contact: Neil Parry, Research Director/Biotechnology Science Leader Quarry Road East, Bebington, Wirral CH63 3JW T: +44 151 641 3581 E: Neil.Parry@unilever.com W: www.unilever.com Contact: Trond Erik Vee Aune, CEO Havnegaten 9 Pirsenteret, 7462, TRONDHEIM, Norway M: +47 950 27 449 E: trond.aune@vectronbiosolutions.com W: www.vectronbiosolutions.com On any given day, two billion people use Unilever products to look good, feel good and get more out of life. Novel technology related to metagenome cloning and high yield recombinant protein expression Veolia Environnment Verdex Ltd Contact: Estelle Brachlianoff, CEO 8th Floor, 210 Pentonville Road, London N1 9JY T: +44 845 60 60 460 E: info@veolia.co.uk W: www.veolia.co.uk Veolia is one of the UK’s specialists in energy and utilities management for industry, healthcare, district heating, public and commercial sector clients. Veolia Environnement is providing creative solutions for our environment. 44 Contact: Ian MacKinnon, Managing Director Roslin Biocentre, Edinburgh EH25 9PP T: +44 131 200 6350 E: ian.mackinnon@verdex.co.uk W: www.verdex.co.uk Verdex produces a range of uv and thermoset varnishes for coatings, inks and textiles. Our Verdanol® products are based upon novel plant-derived formulations. Varnishes are low in viscosity, VOC free and are cost effective.
  • 33. Vernalis Contact: Ian Garland, CEO 100 Berkshire Place, Wharfedale Road, Whinnerish, Berkshire RG41 5RD T: +44 118 938 0000 E: admin@vernalis.com W: www.vernalis.com Photo supplied by Rothamsted Research Viridian International Limited Contact: Cheryl Thallon, Managing Director 15 High March, Daventry, Northamptonshire NN11 4HB T: +44 1327 878050 E: info@viridian-nutrition.com W: www.viridian-nutrition.com Vernalis takes promising product candidates along a commercially-focused path to market. We derive pipeline candidates both from successful collaborations with a number of global pharmaceutical businesses and our own research activities. Vivergo Fuels Limited Contact: Steve Batty, Production Manager Westcott, Hesslewood Country Park, Hessle, East Yorkshire HU13 0PF T: +44 1482 700800 E: steve.batty@vivergofuels.com W: www.vivergofuels.com Viridian Nutrition launched in December 1999 with just 24 products. The company now offers sales, technical and marketing expertise to support more than 180 products and is available in more than a dozen countries. Vivergo Fuels are working to create a world scale biofuels business, which puts something back into the community and region – economically and socially - in which we live and work. Weyland AS Wheyfeed Ltd Contact: Petter Bartz-Johannessen, Managing Director Lonningsflaten 22, 5258, Blomsterdalen, Norway T: +47 55 92 40 00 M: +47 915 38 222 E: pbj@weyland.no W: www.weyland.no Contact: Stuart Bridge, Director Hill Farm, Melton Road, Stanton-on-the-Wolds, Nottingham NG12 5PJ T: +44 115 937 7374 E: info@wheyfeed.co.uk W: www.wheyfeed.co.uk Production of bioethanol based on proprietary technology related to acid hydrolysis of cellulosic material to fermentable sugars. Wheyfeed offers companies in the food, drink and biofuel industries an economic and environmentally beneficial answer to their co-product streams, supplying quality assured liquid co-products as animal feed materials. Xanthella Xellia Pharmaceuticals AS Contact: Douglas McKenzie, Director Marine Resource Centre, Barcaldine, Argyll PA37 1SG T: +44 1631 720632 E: douglas@xanthella.co.uk W: www.xanthella.co.uk Contact: Grethe Evensen, Manager of Fermentation Technology Harbitzalléen 3, 275, OSLO, Norway M: +47 416 85 471 E: grethe.evensen@xellia.com W: www.axellia.com Xanthella’s systems enable our customers to be able to produce algal fuels locally in quantities that not only meet their needs but can be accommodated without causing severely intrusive changes to the local environment. Diversified pharmaceutical company. Production of antibiotics for aquaculture in Oslo. Previously Alpharma. XstalBio Zymtech Production AS Contact: Marie Claire Parker, CEO CIDS, Thomson Building, University Avenue, Glasgow G12 8QQ T: +44 141 330 3298 E: m.c.parker@xstalbio.com W: www.xstalbio.com We focus on delivering value-added solutions to our clients and partners’ needs. XstalBio has successfully formulated over 40 APIs working with many of the world’s top pharmaceutical and biotechnology companies together with the vaccine and animal health industries. Contact: Terje Sølna, CEO 2665, LESJA, Norway M: +47 950 70 784 E: info@zymtech.no W: www.zymtech.no Large scale production of protein hydrolysate and amino acids from fish protein, intended initially for health food. 45
  • 34. MEMORANDUM OF UNDERSTANDING between INNOVATION NORWAY and the TECHNOLOGY STRATEGY BOARD 1. INTRODUCTION a. In order to share costs across governments and maximise exploitation of research and development in areas of common interest the above parties have the intention of first evaluating possible opportunities for bilateral programmes, and then potentially jointly funding R&D activities under the auspices of the following Partnership. b. The purpose of this document is to describe the arrangements for the collaboration between the Innovation Norway (IN) and the Technology Strategy Board (TSB) in the funding and management of the Partnership. c. The activities of the Partnership are jointly administered by the TSB and IN. d. The Partnership will support a number of activities based on Industrial Biotechnology and Biorefining. Both parties believe that these technologies underpin the bioeconomy, which in Europe has a market size of €2 trillion and employs 21.5 million people. Investment in these technologies can help to meet the increasing demand for a sustainable supply of food, industrial products and fuels. Both organisations believe that through joint activities such as knowledge exchange and research and development projects, they will generate economic growth. 2. DEFINITIONS “IN” means Innovation Norway, whose contact details are set out at paragraph 3 below; “TSB” means Technology Strategy Board, whose contact details are set out at paragraph 3 below; “MOU” means this memorandum of understanding; 3. PARTNER DETAILS a. Innovation Norway is a government owned and financed organization offering advisory services and financial support in order to nurture business innovation and entrepreneurship, foster regional development, international cooperation and market access. Innovation Norway acts as an advisor to the Government on industry policy in close cooperation with the Norwegian Research Council. It is a main priority for Innovation Norway to help Norwegian companies become leaders in the utility of renewable resources, e.g. efficient value creation from wood or marine derived biomass, areas where Norway by tradition is strong. b. The Technology Strategy Board’s role is to stimulate technology-enabled innovation in the areas which offer the greatest scope for boosting UK growth and productivity. We promote, support and invest in technology research, development and commercialisation. We spread knowledge, bringing people together to solve problems or make new advances. The UK has strong capabilities in bioscience through a combination of world-class academic research and a vibrant mix of small and medium-sized companies, particularly with an industrial biotechnology expertise. The Technology Strategy Board believes that we can support the UK to realise its potential to become world leader in this area - at the heart of the most dynamic region in the developing bio-based economy. c. Contact Details Party Name Name Title Address Address Address Address Address Tel: Email: Technology Strategy Board Merlin Goldman Lead Technologist A1, North Star House North Star Avenue Swindon UK SN2 1UE +44 1793 442700 merlin.goldman@tsb.gov.uk Party Name Name Title Address Address Address Address Address Tel: Email: Innovation Norway Ole Jørgen Marvik Sector Head, Health and Life Sciences Innovasjon Norge P Box 448 Sentrum .O. (Akersgata 13) 0104 Oslo Norway +47 22 00 25 00 olmar@innovationnorway.no “Partnership” means the plan of shared activities defined in Appendix 1; “Industrial Biotechnology” is the use of biobased feedstocks and biotechnologies, such as biocatalysis, to develop new, more efficient and sustainable methods to produce energy, chemicals and materials. “Biorefining” is the identification, extraction and modification of valuable components from a biobased feedstock. 46
  • 35. d. Other organisations may choose to support or fund elements of the Partnership. If this happens, their additional contributions and requirements may be documented as an Appendix. b. IN’s contribution to the funding for each activity is expected to be in line with standard Innovation Norway policy and criteria. c. TSB’s contribution to the funding for each activity is expected to be in line with standard Technology Strategy 4. DURATION It is planned that this MOU will be in place for the duration of the Partnership. The proposed duration of the Partnership is Board policy and criteria. d. For any jointly funded activities the balance due to one party will be settled by invoicing the other party in arrears. 3 years plus an additional 2 years to complete and evaluate ongoing projects. However, this is an estimate only and is 8. CONTRACTING AND RISK subject to alteration by the IN and TSB at any time. a. The joint IN and TSB grant support for co-funded Projects Partnership activities will be planned and budgeted on a will be awarded through TSB and IN grant offer letters which yearly basis. are legally binding. Any special monitoring or reporting requirements should be included in the offer letters. 5. PROJECT APPLICATION, ASSESSMENT AND MONITORING a. A joint project application, assessment and monitoring b. IN and TSB are only responsible for their own part of cofunded projects according to the respective grant offer letter. process will be designed, based on existing methods where possible. Organisations that receive funding from the 9. CONFIDENTIALITY Partnership for research projects will be funded by their own a. Except as permitted by this paragraph, IN and TSB agree relevant national funding organisation. Decisions on the not to make or permit any disclosure of the existence or the appropriateness of settling claims rest with the relevant terms of or any negotiations related to grant applications. organisation. Also if there are any non-routine matters to be dealt with, such as any concerns related to Project progress, b. Disclosure about grant applications is permitted to the extent issues requiring resolution, or if there is any doubt as to the that it is required by law or the general policies of the appropriateness of settlement of any particular claim or set funding parties, e.g. the disclosure of the name and content of claims, then these will be discussed in reviews to be of the grant letter for successful applicants. arranged by IN and the TSB. c. Announcements, grant calls and press releases about the b. The application and monitoring process may be added as an Appendix when completed. partnership should be mutually agreed by written approval. Permission to publicise the Partnership in general should not be unreasonably withheld or delayed. The MOU document 6. USE AND EXPLOITATION OF INTELLECTUAL itself is public. PROPERTY a. IN and TSB agree not to cause or permit to be done d. Authorised signatory on behalf of the Technology Strategy anything which may damage or endanger the intellectual Board property of the project participant’s title to such intellectual Name: David Bott property, or assist or allow others to do so. Director of Innovation Programmes Technology Strategy Board b. The use of all intellectual property rights is to be determined by the project participant which owns those rights. North Star House, North Star Avenue, Swindon, Wiltshire SN2 1UE 7. FINANCIAL ARRANGEMENTS Authorised signatory on behalf of Innovation Norway a. As a general principle, TSB and IN will support the activities Name: Gunn Ovesen of project participants from their respective countries, i.e. Managing Director TSB will support UK driven research and IN Norwegian Innovasjon Norge driven research. Akersgata 13, 0104 Oslo, Norway 47
  • 36. Appendix 1 – Proposed Activities 1. Consultancy – identifying opportunities Tender and manage the completion of a report on the high level opportunities and synergies for Norway and the UK. A follow up report focusing on more specific market or technology areas may be commissioned on completion of the initial study. The initial report will be funded jointly by the UK’s Biosciences KTN (a networking organisation funded by the Technology Strategy Board) and Innovation Norway. 2. Online Networking Innovation Norway intends to build a national Industrial Biotechnology web portal. Technology Strategy Board will generate a UK-Norway group on its Connect site to promote online networking. One could envision building a system for functional integration between the national relevant web sites, and this integration may involve some cost. Management time will be required on both sides. 3. Physical Networking In order to identify and encourage collaborative projects, the partners intend to organise networking events in both the UK and Norway. These events could be study trips, seminars, matchmaking or could also focus on knowledge transfer within a specific topic or opportunities for venture capital. They might also be aligned to other events e.g. conferences or site visits. The parties envision 2-4 events per year, contingent on each party’s annual budget. Management time will be required on both sides. 4. Pilot and Demonstration Facilities Industrial biotechnology and biorefining projects often require access to pilot or demonstration facilities and expertise on process development and scaling-up. The UK and Norway has a number of centres of excellence that provide these capabilities. These facilities will be highlighted to stakeholders in both countries, through presentations or study tours. If such facilities identify areas of cross-border complementarity , for instance if one UK facility focuses on fermentation technologies, while a Norwegian facility focuses on separation technologies, the facilities may wish to form a business relationship involving co-marketing, exchange of personnel and joint management of specific projects. Exchange of technical personnel to encourage knowledge transfer and technical interaction might be supported. Management time to organise visits and stimulate partnerships will be required on both sides. 5. Norway-UK collaborative R&D projects Projects may include companies, research and technology organisations and academic research groups, funded through a competitive process. Projects could be at any stage along the 48 technology or product development chain, but the specifications and budget for joint funding programs will need to be worked out and agreed before any calls are announced. Management time will be required for working out program details and potentially for managing calls. Based on previous programs the parties envision that a budget of 5 mill GBP could support 5-15 projects over the term of the agreement. Successful projects will be competing with other opportunities, hence this number is only indicative, reflecting the expected amount of opportunities and associated funding requirement and not a commitment on the parties to a specific budget frame. Whether projects involving only academia will be funded will depend on the participation of the respective Research Councils. The general principle is that all grants should be based on predefined policy and quality criteria. Moreover, each country would only be obliged to fund their own organisations (i.e. their part of the budget of successful projects). Each call for grant applications will have its own requirements e.g. topic, timing, minimum size of project, assessment criteria or a minimum level of bilateralism. Examples of potential topics: a. Feasibility projects where marine or terrestrial feedstocks are used to create high value products and biofuel b. Development of novel technologies for biocatalytic conversion c. Pilot scale demonstration of novel processes An alternative funding scheme would follow the Norwegian IFU contracts, where cost is split between a larger business partner (a so called “demanding customer”), a technology developer (typically an SME) and Innovation Norway. This scheme would be suitable for projects involving a UK large chemical company and a Norwegian SME developing a relevant process. Knowledge Transfer Partnerships is Europe’s leading programme helping businesses to improve their competitiveness and productivity through the better use of knowledge, technology and skills that reside within the UK knowledge base. It might be possible for UK companies to accept graduates from Norwegian universities or vice versa. 6. European Projects The Parties have the intention to monitor EU calls for funding and encourage consortia containing UK and Norwegian partners to bid into the calls assisted by the activities 1-3 above. For instance, the ERANET in Industrial Biotechnology or the CSA action on Marine Biotechnology.
  • 37. Index of Advertisers Advertister Page Almac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18 Applikon Biotechnology . . . . . . . . . . . . . . . . . . .15 Benham Publishing . . . . . . . . . . . . . . . . . . . . . . .51 Biocatalysts . . . . . . . . . . . . . . . . . . . . . . . . . . . . .19 Biofortuna . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21 Biome Technologies plc . . . . . . . . . . . . . . . . . . .21 Biomega . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13 Biosentrum AS . . . . . . . . . . . . . . . . . . . . . . . . . . .19 Bouygues Energies & Services . . . . . . . . . . . . . .15 Centre for Process Innovation (CPI) . . . . . . . . . . .4 Croda Europe Ltd . . . . . . . . . . . . . . . . . . . . . . . . .6 Fujifilm Diosynth Biotechnologies . . . . . . . . . . . .21 GlycoMar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18 Medimmune . . . . . . . . . . . . . . . . . . . . . . . . . . . .17 MicroA AS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .18 Mylnefield Research Services . . . . . . . . . . . . . . .20 NCIMB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .20 Novus Biologicals . . . . . . . . . . . . . . . . . . . . . . . .13 Procter & Gamble . . . . . . . . . . . . . . . . . . . . . . . .52 Unilever . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2 49
  • 38. Check your details! Is your listing accurate? If your listing is inaccurate please contact us. If your listing is inaccurate please contact us. Biosciences KTN We can update your information over the phone on +44 (0)131 651 7332 or by email to michelle.carter@biosciencektn.com. Alternatively, you can fill in the form below and submit it to us by post: Innovation Norway We can update your information over the phone on +47 909 66 998 or by email to marit.valseth@innovationnorway.no Alternatively, you can fill in the form below and submit it to us by post: Biosciences KTN The Roslin Institute Easter Bush Midlothian EH25 9RG Innovation Norway Attn: Marit S. Valseth P 448 Sentrum .O. NO-0104 Oslo Norway If you would like to be listed in next year’s directory please supply the following information to any of the contact points above. If you would like to be listed in next year’s directory please supply the following information to any of the contact points above. Company Name: ............................................................................................ Contact: ................................................................................................... Position: ................................................................................................... Address: .................................................................................................. ........................................................................................................... ........................................................................................................... PostCode: ................................................................................................. Telephone: ................................................................................................. Fax: ...................................................................................................... Email: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Website: ................................................................................................... Company Activities (maximum of 20 words): ...................................................................... ........................................................................................................... ........................................................................................................... ........................................................................................................... ........................................................................................................... 50
  • 39. 51

×